{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:13:58Z","timestamp":1792174438692,"version":"4.4.0"},"reference-count":518,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301629"],"award-info":[{"award-number":["82301629"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024MH129"],"award-info":[{"award-number":["ZR2024MH129"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"STI2030-Major Projects","award":["2021ZD0200900"],"award-info":[{"award-number":["2021ZD0200900"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuroinflammation is increasingly recognized as a key contributor and amplifier associated with the pathogenesis of Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD). Neuroinflammation occurs throughout various stages of these diseases with expanding complexity. Currently, no effective therapies exist that specifically target neuroinflammatory processes in these disorders. In this review, we synthesize current understanding of central and peripheral inflammatory mechanisms implicated in both diseases. We illustrate how endogenous pathological triggers, such as amyloid-\u03b2 (A\u03b2) peptide, hyperphosphorylated tau, and \u03b1-synuclein, activate glial cells, contributing to chronic neuroinflammation that exacerbates neurodegeneration. Additionally, peripheral factors, including systemic inflammation, environmental exposures, and gut-brain axis interactions, are discussed for their roles in modulating neuroinflammatory responses. Notably, the underappreciated roles of oligodendrocyte precursor cells and oligodendrocytes in neuroimmune crosstalk are also highlighted. Advanced methodologies, including glial cell imaging, single-cell transcriptomics, and human induced pluripotent stem cell-derived organoid models, are providing unprecedented insights into the molecular and cellular mechanisms underlying neuroinflammation. Finally, we evaluate emerging therapeutic strategies and ongoing clinical trials targeting neuroinflammatory pathways and analyze the potential of immunomodulatory approaches to slow disease progression. This comprehensive review emphasizes that precise targeting of neuroinflammation represents a tractable strategy for developing effective disease\u2011modifying treatments for AD and PD.<\/jats:p>","DOI":"10.1186\/s40035-026-00571-3","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:50:34Z","timestamp":1785293434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuroinflammation in Alzheimer\u2019s and Parkinson\u2019s diseases: pathogenic mechanisms and therapeutic strategies"],"prefix":"10.1186","volume":"15","author":[{"given":"Qin-qin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-shun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-9178","authenticated-orcid":false,"given":"Jia-wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"5","key":"571_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, et al. Neuroinflammation in Alzheimer disease. Nat Rev Immunol. 2025;25(5):321\u201352.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"571_CR2","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41418-020-00704-9","volume":"28","author":"Y Fang","year":"2021","unstructured":"Fang Y, Jiang Q, Li S, Zhu H, Xu R, Song N, et al. Opposing functions of beta-arrestin 1 and 2 in Parkinson\u2019s disease via microglia inflammation and Nprl3. Cell Death Differ. 2021;28(6):1822\u201336.","journal-title":"Cell Death Differ"},{"issue":"7","key":"571_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T. Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells. 2023;12(7):1012.","journal-title":"Cells"},{"issue":"4","key":"571_CR4","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"Alzheimer\u2019s disease facts and figures","year":"2023","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2023;19(4):1598\u2013695.","journal-title":"Alzheimers Dement"},{"issue":"10423","key":"571_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson\u2019s disease. Lancet. 2024;403(10423):283\u201392.","journal-title":"Lancet"},{"issue":"2","key":"571_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","volume":"103","author":"A Atri","year":"2019","unstructured":"Atri A. The Alzheimer\u2019s Disease clinical spectrum: Diagnosis and management. Med Clin North Am. 2019;103(2):263\u201393.","journal-title":"Med Clin North Am"},{"issue":"1","key":"571_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s10020-021-00301-7","volume":"27","author":"S Hirano","year":"2021","unstructured":"Hirano S. Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson\u2019s disease. Mol Med. 2021;27(1):40.","journal-title":"Mol Med"},{"issue":"12","key":"571_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0891-5849(02)00804-3","volume":"32","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Ischiropoulos H, Lee VM, Trojanowski JQ. The relationship between oxidative\/nitrative stress and pathological inclusions in Alzheimer\u2019s and Parkinson\u2019s diseases. Free Radic Biol Med. 2002;32(12):1264\u201375.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"571_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJMra2401857","volume":"391","author":"CM Tanner","year":"2024","unstructured":"Tanner CM, Ostrem JL. Parkinson\u2019s disease. N Engl J Med. 2024;391(5):442\u201352.","journal-title":"N Engl J Med"},{"issue":"2","key":"571_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X. Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell. 2025;16(2):83\u2013120.","journal-title":"Protein Cell"},{"issue":"3","key":"571_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1007\/s10753-024-02125-z","volume":"48","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Muhammad FA, Singh A, Mustafa MA, Al Zuhairi RAH, Ghildiyal P, et al. MicroRNAs modulating neuroinflammation in Parkinson\u2019s disease. Inflammation. 2025;48(3):1042\u201362.","journal-title":"Inflammation"},{"issue":"2","key":"571_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14393","volume":"24","author":"PP Liu","year":"2025","unstructured":"Liu PP, Liu XH, Ren MJ, Liu XT, Shi XQ, Li ML, et al. Neuronal cathepsin S increases neuroinflammation and causes cognitive decline via CX3CL1-CX3CR1 axis and JAK2-STAT3 pathway in aging and Alzheimer\u2019s disease. Aging Cell. 2025;24(2):e14393.","journal-title":"Aging Cell"},{"issue":"2","key":"571_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115266","volume":"44","author":"Q Ma","year":"2025","unstructured":"Ma Q, Tian JL, Lou Y, Guo R, Ma XR, Wu JB, et al. Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson\u2019s disease via the prosaposin-GPR37-IL-6 axis. Cell Rep. 2025;44(2):115266.","journal-title":"Cell Rep"},{"issue":"8","key":"571_CR14","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1038\/s41591-025-03833-1","volume":"31","author":"M Ali","year":"2025","unstructured":"Ali M, Erabadda B, Chen Y, Xu Y, Gong K, Liu M, et al. Shared and disease-specific pathways in frontotemporal dementia and Alzheimer\u2019s and Parkinson\u2019s diseases. Nat Med. 2025;31(8):2567\u201377.","journal-title":"Nat Med"},{"key":"571_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106794","volume":"207","author":"ML Bolen","year":"2025","unstructured":"Bolen ML, Gomes BN, Gill B, Menees KB, Staley H, Jernigan J, et al. Peripheral blood immune cells from individuals with Parkinson\u2019s disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs. Neurobiol Dis. 2025;207:106794.","journal-title":"Neurobiol Dis"},{"key":"571_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.796867","volume":"12","author":"J Xie","year":"2021","unstructured":"Xie J, Van Hoecke L, Vandenbroucke RE. The impact of systemic inflammation on Alzheimer\u2019s disease pathology. Front Immunol. 2021;12:796867.","journal-title":"Front Immunol"},{"issue":"1","key":"571_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):267.","journal-title":"Signal Transduct Target Ther"},{"key":"571_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener. 2015;4:19.","journal-title":"Transl Neurodegener"},{"issue":"7638","key":"571_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"3","key":"571_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312\u201325.","journal-title":"Nat Neurosci"},{"issue":"3","key":"571_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157\u201372.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"571_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI184656","volume":"135","author":"Q Tian","year":"2025","unstructured":"Tian Q, Li J, Wu B, Pang Y, He W, Xiao Q, et al. APP lysine 612 lactylation ameliorates amyloid pathology and memory decline in Alzheimer\u2019s disease. J Clin Invest. 2025;135(1):e184656.","journal-title":"J Clin Invest"},{"key":"571_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bbi.2023.11.008","volume":"115","author":"A Vilella","year":"2024","unstructured":"Vilella A, Bodria M, Papotti B, Zanotti I, Zimetti F, Remaggi G, et al. PCSK9 ablation attenuates Abeta pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice. Brain Behav Immun. 2024;115:517\u201334.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"571_CR24","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s42003-024-06615-6","volume":"7","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Guo X, Li S, Wu Y, Zhu F, Qin C, et al. Naringenin ameliorates amyloid-beta pathology and neuroinflammation in Alzheimer\u2019s disease. Commun Biol. 2024;7(1):912.","journal-title":"Commun Biol"},{"issue":"8","key":"571_CR25","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1002\/alz.14047","volume":"20","author":"Y Du","year":"2024","unstructured":"Du Y, Guo T, Hao Y, Li C, Tang L, Li X, et al. PKCdelta serves as a potential biomarker and therapeutic target for microglia-mediated neuroinflammation in Alzheimer\u2019s disease. Alzheimers Dement. 2024;20(8):5511\u201327.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"571_CR26","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1093\/brain\/awae221","volume":"147","author":"SH Lee","year":"2024","unstructured":"Lee SH, Bae EJ, Perez-Acuna D, Jung MK, Han JW, Mook-Jung I, et al. Amyloid-beta-activated microglia can induce compound proteinopathies. Brain. 2024;147(12):4105\u201320.","journal-title":"Brain"},{"issue":"1","key":"571_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation. 2023;20(1):165.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"571_CR28","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","volume":"99","author":"KH Strang","year":"2019","unstructured":"Strang KH, Golde TE, Giasson BI. MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab Invest. 2019;99(7):912\u201328.","journal-title":"Lab Invest"},{"issue":"4","key":"571_CR29","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/brain\/awac318","volume":"146","author":"M Ponnusamy","year":"2023","unstructured":"Ponnusamy M, Wang S, Yuksel M, Hansen MT, Blazier DM, McMillan JD, et al. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model. Brain. 2023;146(4):1561\u201379.","journal-title":"Brain"},{"issue":"1","key":"571_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-021-02182-3","volume":"18","author":"XY Sun","year":"2021","unstructured":"Sun XY, Li LJ, Dong QX, Zhu J, Huang YR, Hou SJ, et al. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer\u2019s disease. J Neuroinflammation. 2021;18(1):131.","journal-title":"J Neuroinflammation"},{"issue":"18","key":"571_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161987","volume":"133","author":"D Dutta","year":"2023","unstructured":"Dutta D, Jana M, Paidi RK, Majumder M, Raha S, Dasarathy S, et al. Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer\u2019s disease-related mouse models. J Clin Invest. 2023;133(18):e161987.","journal-title":"J Clin Invest"},{"issue":"1","key":"571_CR32","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1126\/sciadv.abq5423","volume":"9","author":"E Ochoa","year":"2023","unstructured":"Ochoa E, Ramirez P, Gonzalez E, De Mange J, Ray WJ, Bieniek KF, et al. Pathogenic tau-induced transposable element-derived dsRNA drives neuroinflammation. Sci Adv. 2023;9(1):5423.","journal-title":"Sci Adv"},{"key":"571_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.acc.2020.08.007","volume":"103","author":"A Bougea","year":"2021","unstructured":"Bougea A. Synuclein in neurodegeneration. Adv Clin Chem. 2021;103:97\u2013134.","journal-title":"Adv Clin Chem"},{"issue":"1","key":"571_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13024-023-00686-5","volume":"18","author":"L Geng","year":"2023","unstructured":"Geng L, Gao W, Saiyin H, Li Y, Zeng Y, Zhang Z, et al. MLKL deficiency alleviates neuroinflammation and motor deficits in the alpha-synuclein transgenic mouse model of Parkinson\u2019s disease. Mol Neurodegener. 2023;18(1):94.","journal-title":"Mol Neurodegener"},{"key":"571_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.toxlet.2016.11.002","volume":"265","author":"QS Zhang","year":"2017","unstructured":"Zhang QS, Heng Y, Yuan YH, Chen NH. Pathological alpha-synuclein exacerbates the progression of Parkinson\u2019s disease through microglial activation. Toxicol Lett. 2017;265:30\u20137.","journal-title":"Toxicol Lett"},{"issue":"8","key":"571_CR36","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41419-021-04049-0","volume":"12","author":"TW Chou","year":"2021","unstructured":"Chou TW, Chang NP, Krishnagiri M, Patel AP, Lindman M, Angel JP, et al. Fibrillar alpha-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-kappaB. Cell Death Dis. 2021;12(8):756.","journal-title":"Cell Death Dis"},{"key":"571_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115735","volume":"168","author":"Q Huang","year":"2023","unstructured":"Huang Q, Yang P, Liu Y, Ding J, Lu M, Hu G. The interplay between alpha-Synuclein and NLRP3 inflammasome in Parkinson\u2019s disease. Biomed Pharmacother. 2023;168:115735.","journal-title":"Biomed Pharmacother"},{"key":"571_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, et al. Targeting microglial alpha-Synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease. Front Immunol. 2021;12:719807.","journal-title":"Front Immunol"},{"key":"571_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103256","volume":"147","author":"YH Choe","year":"2024","unstructured":"Choe YH, Jo MG, Kim BG, Lee S, Lee B, Kim SH, et al. The autoimmune response induced by alpha-synuclein peptides drives neuronal cell death and glial cell activation. J Autoimmun. 2024;147:103256.","journal-title":"J Autoimmun"},{"issue":"1","key":"571_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/alz.13490","volume":"20","author":"S Gaikwad","year":"2024","unstructured":"Gaikwad S, Senapati S, Haque MA, Kayed R. Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer\u2019s disease: evidence from clinical and preclinical studies. Alzheimers Dement. 2024;20(1):709\u201327.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"571_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13195-022-01150-0","volume":"14","author":"KH Shim","year":"2022","unstructured":"Shim KH, Kang MJ, Youn YC, An SSA, Kim S. Alpha-synuclein: a pathological factor with Abeta and tau and biomarker in Alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14(1):201.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"571_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00822-3","volume":"20","author":"N Franzmeier","year":"2025","unstructured":"Franzmeier N, Roemer-Cassiano SN, Bernhardt AM, Dehsarvi A, Dewenter A, Steward A, et al. Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer\u2019s disease. Mol Neurodegener. 2025;20(1):31.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"571_CR43","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1007\/s00415-018-9100-8","volume":"266","author":"EW Lim","year":"2019","unstructured":"Lim EW, Aarsland D, Ffytche D, Taddei RN, van Wamelen DJ, Wan YM, et al. Amyloid-beta and Parkinson\u2019s disease. J Neurol. 2019;266(11):2605\u201319.","journal-title":"J Neurol"},{"issue":"2","key":"571_CR44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/brain\/awad388","volume":"147","author":"Y Chu","year":"2024","unstructured":"Chu Y, Hirst WD, Federoff HJ, Harms AS, Stoessl AJ, Kordower JH. Nigrostriatal tau pathology in parkinsonism and Parkinson\u2019s disease. Brain. 2024;147(2):444\u201357.","journal-title":"Brain"},{"issue":"2","key":"571_CR45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","volume":"105","author":"F Bassil","year":"2020","unstructured":"Bassil F, Brown HJ, Pattabhiraman S, Iwasyk JE, Maghames CM, Meymand ES, et al. Amyloid-Beta (Abeta) plaques promote seeding and spreading of alpha-Synuclein and Tau in a mouse model of Lewy Body Disorders with Abeta pathology. Neuron. 2020;105(2):260\u201375.","journal-title":"Neuron"},{"issue":"1","key":"571_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-021-00486-9","volume":"16","author":"GM Lloyd","year":"2021","unstructured":"Lloyd GM, Dhillon JS, Gorion KM, Riffe C, Fromholt SE, Xia Y, et al. Collusion of alpha-Synuclein and Abeta aggravating co-morbidities in a novel prion-type mouse model. Mol Neurodegener. 2021;16(1):63.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"571_CR47","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/ptr.8461","volume":"39","author":"B Li","year":"2025","unstructured":"Li B, Wang L, Xiao Y, Wang Y, Wang Y, Peng Y, et al. Gastrodin ameliorates tau pathology and BBB dysfunction in 3xTg-AD transgenic mice by regulating the ADRA1\/NF-kappaB\/NLRP3 pathway to reduce neuroinflammation. Phytother Res. 2025;39(5):1996\u20132016.","journal-title":"Phytother Res"},{"issue":"6","key":"571_CR48","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.molmed.2018.04.003","volume":"24","author":"R Rua","year":"2018","unstructured":"Rua R, McGavern DB. Advances in meningeal immunity. Trends Mol Med. 2018;24(6):542\u201359.","journal-title":"Trends Mol Med"},{"key":"571_CR49","unstructured":"Ghannam JY, Al Kharazi KA. Neuroanatomy, cranial meninges. StatPearls. 2023."},{"key":"571_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1181071","volume":"17","author":"A Abbaoui","year":"2023","unstructured":"Abbaoui A, Fatoba O, Yamashita T. Meningeal T cells function in the central nervous system homeostasis and neurodegenerative diseases. Front Cell Neurosci. 2023;17:1181071.","journal-title":"Front Cell Neurosci"},{"key":"571_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1531068","volume":"16","author":"PU Patel","year":"2025","unstructured":"Patel PU, Regmi A, Dass AI, Rojas OL. Immune conversations at the border: meningeal immunity in health and disease. Front Immunol. 2025;16:1531068.","journal-title":"Front Immunol"},{"issue":"5","key":"571_CR52","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.20091419","volume":"207","author":"NC Derecki","year":"2010","unstructured":"Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR, et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med. 2010;207(5):1067\u201380.","journal-title":"J Exp Med"},{"issue":"4","key":"571_CR53","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2020.12.040","volume":"184","author":"J Rustenhoven","year":"2021","unstructured":"Rustenhoven J, Drieu A, Mamuladze T, de Lima KA, Dykstra T, Wall M, et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell. 2021;184(4):1000-16 e27.","journal-title":"Cell"},{"issue":"11","key":"571_CR54","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41590-020-0776-4","volume":"21","author":"K Alves de Lima","year":"2020","unstructured":"Alves de Lima K, Rustenhoven J, Da Mesquita S, Wall M, Salvador AF, Smirnov I, et al. Meningeal gammadelta T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat Immunol. 2020;21(11):1421\u20139.","journal-title":"Nat Immunol"},{"issue":"7612","key":"571_CR55","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature18626","volume":"535","author":"AJ Filiano","year":"2016","unstructured":"Filiano AJ, Xu Y, Tustison NJ, Marsh RL, Baker W, Smirnov I, et al. Unexpected role of interferon-gamma in regulating neuronal connectivity and social behaviour. Nature. 2016;535(7612):425\u20139.","journal-title":"Nature"},{"issue":"11","key":"571_CR56","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.immuni.2022.10.005","volume":"55","author":"J Rebejac","year":"2022","unstructured":"Rebejac J, Eme-Scolan E, Arnaud Paroutaud L, Kharbouche S, Teleman M, Spinelli L, et al. Meningeal macrophages protect against viral neuroinfection. Immunity. 2022;55(11):2103-17 e10.","journal-title":"Immunity"},{"issue":"1","key":"571_CR57","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12974-024-03252-y","volume":"21","author":"D Gao","year":"2024","unstructured":"Gao D, Zou B, Zhu K, Bi S, Zhang W, Yang X, et al. Enhancing Th17 cells drainage through meningeal lymphatic vessels alleviate neuroinflammation after subarachnoid hemorrhage. J Neuroinflammation. 2024;21(1):269.","journal-title":"J Neuroinflammation"},{"issue":"7858","key":"571_CR58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41586-021-03489-0","volume":"593","author":"S Da Mesquita","year":"2021","unstructured":"Da Mesquita S, Papadopoulos Z, Dykstra T, Brase L, Farias FG, Wall M, et al. Meningeal lymphatics affect microglia responses and anti-Abeta immunotherapy. Nature. 2021;593(7858):255\u201360.","journal-title":"Nature"},{"issue":"1","key":"571_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-023-00645-0","volume":"18","author":"S Rego","year":"2023","unstructured":"Rego S, Sanchez G, Da Mesquita S. Current views on meningeal lymphatics and immunity in aging and Alzheimer\u2019s disease. Mol Neurodegener. 2023;18(1):55.","journal-title":"Mol Neurodegener"},{"issue":"7","key":"571_CR60","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276-90 e17.","journal-title":"Cell"},{"issue":"1","key":"571_CR61","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med. 2020;26(1):131\u201342.","journal-title":"Nat Med"},{"issue":"3","key":"571_CR62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41591-020-01198-1","volume":"27","author":"XB Ding","year":"2021","unstructured":"Ding XB, Wang XX, Xia DH, Liu H, Tian HY, Fu Y, et al. Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson\u2019s disease. Nat Med. 2021;27(3):411\u20138.","journal-title":"Nat Med"},{"key":"571_CR63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-019-0147-y","volume":"8","author":"W Zou","year":"2019","unstructured":"Zou W, Pu T, Feng W, Lu M, Zheng Y, Du R, et al. Blocking meningeal lymphatic drainage aggravates Parkinson\u2019s disease-like pathology in mice overexpressing mutated alpha-synuclein. Transl Neurodegener. 2019;8:7.","journal-title":"Transl Neurodegener"},{"issue":"12","key":"571_CR64","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1016\/j.celrep.2020.02.109","volume":"30","author":"P Suss","year":"2020","unstructured":"Suss P, Hoffmann A, Rothe T, Ouyang Z, Baum W, Staszewski O, et al. Chronic peripheral inflammation causes a region-specific myeloid response in the central nervous system. Cell Rep. 2020;30(12):4082\u201395.","journal-title":"Cell Rep"},{"issue":"1","key":"571_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12974-024-03318-x","volume":"22","author":"FS Leser","year":"2025","unstructured":"Leser FS, Junyor FS, Pagnoncelli IB, Delgado AB, Medeiros I, Nobrega ACC, et al. CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson\u2019s disease models. J Neuroinflammation. 2025;22(1):31.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"571_CR66","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.4103\/1673-5374.306060","volume":"16","author":"P Subeta","year":"2021","unstructured":"Subeta P, Lana AJ, Schlachetzki JCM. Chronic peripheral inflammation: a possible contributor to neurodegenerative diseases. Neural Regen Res. 2021;16(9):1711\u20134.","journal-title":"Neural Regen Res"},{"issue":"11","key":"571_CR67","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"571_CR68","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-024-00722-y","volume":"19","author":"GC Brown","year":"2024","unstructured":"Brown GC, Heneka MT. The endotoxin hypothesis of Alzheimer\u2019s disease. Mol Neurodegener. 2024;19(1):30.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"571_CR69","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453\u201362.","journal-title":"Glia"},{"issue":"2","key":"571_CR70","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0192623307313011","volume":"36","author":"L Calderon-Garciduenas","year":"2008","unstructured":"Calderon-Garciduenas L, Solt AC, Henriquez-Roldan C, Torres-Jardon R, Nuse B, Herritt L, et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol Pathol. 2008;36(2):289\u2013310.","journal-title":"Toxicol Pathol"},{"issue":"11","key":"571_CR71","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.cmet.2024.08.007","volume":"36","author":"F Ma","year":"2024","unstructured":"Ma F, Li Z, Liu H, Chen S, Zheng S, Zhu J, et al. Dietary-timing-induced gut microbiota diurnal oscillations modulate inflammatory rhythms in rheumatoid arthritis. Cell Metab. 2024;36(11):2367-82 e5.","journal-title":"Cell Metab"},{"issue":"5","key":"571_CR72","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/03009742.2025.2503055","volume":"54","author":"C Kodishala","year":"2025","unstructured":"Kodishala C, Jose George R, Javed R, Lovering EJ, Crowson CS, Lennon RJ, et al. Role of rheumatoid arthritis flare in the risk of Alzheimer\u2019s disease and related dementias: a population-based cohort study. Scand J Rheumatol. 2025;54(5):331\u20138.","journal-title":"Scand J Rheumatol"},{"issue":"7111","key":"571_CR73","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nature05181","volume":"443","author":"JC Kash","year":"2006","unstructured":"Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature. 2006;443(7111):578\u201381.","journal-title":"Nature"},{"issue":"1","key":"571_CR74","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28411","volume":"36","author":"EM Kline","year":"2021","unstructured":"Kline EM, Houser MC, Herrick MK, Seibler P, Klein C, West A, et al. Genetic and environmental factors in Parkinson\u2019s Disease converge on immune function and inflammation. Mov Disord. 2021;36(1):25\u201336.","journal-title":"Mov Disord"},{"key":"571_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2025.115671","volume":"201","author":"P Gul","year":"2025","unstructured":"Gul P, Khan J, Li Q, Liu K. Moringa oleifera in a modern time: a comprehensive review of its nutritional and bioactive composition as a natural solution for managing diabetes mellitus by reducing oxidative stress and inflammation. Food Res Int. 2025;201:115671.","journal-title":"Food Res Int"},{"issue":"1","key":"571_CR76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41569-024-01062-6","volume":"22","author":"LL Camargo","year":"2025","unstructured":"Camargo LL, Rios FJ, Montezano AC, Touyz RM. Reactive oxygen species in hypertension. Nat Rev Cardiol. 2025;22(1):20\u201337.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"571_CR77","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","volume":"10","author":"DE Barnes","year":"2011","unstructured":"Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence. Lancet Neurol. 2011;10(9):819\u201328.","journal-title":"Lancet Neurol"},{"issue":"1","key":"571_CR78","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/gutjnl-2020-320789","volume":"70","author":"B Zhang","year":"2021","unstructured":"Zhang B, Wang HE, Bai YM, Tsai SJ, Su TP, Chen TJ, et al. Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut. 2021;70(1):85\u201391.","journal-title":"Gut"},{"issue":"11","key":"571_CR79","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"C Chen","year":"2022","unstructured":"Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J, et al. Gut microbiota regulate Alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut. 2022;71(11):2233\u201352.","journal-title":"Gut"},{"issue":"7164","key":"571_CR80","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature06246","volume":"449","author":"R Medzhitov","year":"2007","unstructured":"Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007;449(7164):819\u201326.","journal-title":"Nature"},{"key":"571_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122132","volume":"333","author":"L Bello-Corral","year":"2023","unstructured":"Bello-Corral L, Alves-Gomes L, Fernandez-Fernandez JA, Fernandez-Garcia D, Casado-Verdejo I, Sanchez-Valdeon L. Implications of gut and oral microbiota in neuroinflammatory responses in Alzheimer\u2019s disease. Life Sci. 2023;333:122132.","journal-title":"Life Sci"},{"key":"571_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021001","author":"JT Matheson","year":"2023","unstructured":"Matheson JT, Holsinger RMD. The role of fecal microbiota transplantation in the treatment of neurodegenerative diseases: a review. Int J Mol Sci.\u00a02023;24(2):1001.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"571_CR83","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/1673-5374.317981","volume":"17","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Yuan M, Liu Y, Yang F, Chen WZ, Xu ZZ, et al. Association between inflammatory bowel diseases and Parkinson\u2019s disease: systematic review and meta-analysis. Neural Regen Res. 2022;17(2):344\u201353.","journal-title":"Neural Regen Res"},{"key":"571_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13060772","author":"L Giuli","year":"2023","unstructured":"Giuli L, Maestri M, Santopaolo F, Pompili M, Ponziani FR. Gut microbiota and neuroinflammation in acute liver failure and chronic liver disease. Metabolites.\u00a02023;13(6):772.","journal-title":"Metabolites"},{"issue":"5","key":"571_CR85","doi-asserted-by":"publisher","first-page":"G749","DOI":"10.1152\/ajpgi.00184.2011","volume":"301","author":"C D\u2019Mello","year":"2011","unstructured":"D\u2019Mello C, Swain MG. Liver-brain inflammation axis. Am J Physiol Gastrointest Liver Physiol. 2011;301(5):G749\u201361.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"571_CR86","unstructured":"Kim Y, Jung J, Cirunduzi AC, Yoon S, Bang S, Yang SH. Organ-brain axis in Alzheimer\u2019s disease: a systemic perspective on pathogenesis and progression. Aging Dis. 2026."},{"issue":"1","key":"571_CR87","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1038\/s41467-025-58356-7","volume":"16","author":"KJ Chung","year":"2025","unstructured":"Chung KJ, Abdelhafez YG, Spencer BA, Jones T, Tran Q, Nardo L, et al. Quantitative PET imaging and modeling of molecular blood-brain barrier permeability. Nat Commun. 2025;16(1):3076.","journal-title":"Nat Commun"},{"issue":"1","key":"571_CR88","doi-asserted-by":"publisher","first-page":"2167172","DOI":"10.1080\/19490976.2023.2167172","volume":"15","author":"J Jin","year":"2023","unstructured":"Jin J, Xu Z, Zhang L, Zhang C, Zhao X, Mao Y, et al. Gut-derived beta-amyloid: likely a centerpiece of the gut-brain axis contributing to Alzheimer\u2019s pathogenesis. Gut Microbes. 2023;15(1):2167172.","journal-title":"Gut Microbes"},{"issue":"21","key":"571_CR89","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.neuron.2024.08.003","volume":"112","author":"J Xiang","year":"2024","unstructured":"Xiang J, Tang J, Kang F, Ye J, Cui Y, Zhang Z, et al. Gut-induced alpha-synuclein and tau propagation initiate Parkinson\u2019s and Alzheimer\u2019s disease co-pathology and behavior impairments. Neuron. 2024;112(21):3585-601 e5.","journal-title":"Neuron"},{"issue":"11","key":"571_CR90","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41423-023-01043-8","volume":"20","author":"T Mamuladze","year":"2023","unstructured":"Mamuladze T, Kipnis J. Type 2 immunity in the brain and brain borders. Cell Mol Immunol. 2023;20(11):1290\u20139.","journal-title":"Cell Mol Immunol"},{"issue":"107","key":"571_CR91","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adp6450","volume":"10","author":"NM Mroz","year":"2025","unstructured":"Mroz NM, Chiaranunt P, Molofsky AV, Molofsky AB. Cross-regulation between the nervous system and type 2 immunity. Sci Immunol. 2025;10(107):eadp6450.","journal-title":"Sci Immunol"},{"key":"571_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115147","volume":"162","author":"JD Godavarthi","year":"2025","unstructured":"Godavarthi JD, Pillai A, Morales R, Giridharan VV. Innate immunity in the brain: ILC2s as modulators of CNS disorders. Int Immunopharmacol. 2025;162:115147.","journal-title":"Int Immunopharmacol"},{"key":"571_CR93","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190915","author":"ITH Fung","year":"2020","unstructured":"Fung ITH, Sankar P, Zhang Y, Robison LS, Zhao X, D\u2019Souza SS, et al. Activation of group 2 innate lymphoid cells alleviates aging-associated cognitive decline. J Exp Med.\u00a02020;217(4):e20190915.","journal-title":"J Exp Med"},{"key":"571_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/srep16622","volume":"5","author":"LB Wood","year":"2015","unstructured":"Wood LB, Winslow AR, Proctor EA, McGuone D, Mordes DA, Frosch MP, et al. Identification of neurotoxic cytokines by profiling Alzheimer\u2019s disease tissues and neuron culture viability screening. Sci Rep. 2015;5:16622.","journal-title":"Sci Rep"},{"issue":"19","key":"571_CR95","doi-asserted-by":"publisher","first-page":"E2705","DOI":"10.1073\/pnas.1604032113","volume":"113","author":"AK Fu","year":"2016","unstructured":"Fu AK, Hung KW, Yuen MY, Zhou X, Mak DS, Chan IC, et al. IL-33 ameliorates Alzheimer\u2019s disease-like pathology and cognitive decline. Proc Natl Acad Sci USA. 2016;113(19):E2705\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"571_CR96","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.bbi.2020.04.007","volume":"88","author":"CA Aguirre","year":"2020","unstructured":"Aguirre CA, Concetta Morale M, Peng Q, Sanchez-Alavez M, Cintron-Colon R, Feng K, et al. Two single nucleotide polymorphisms in IL13 and IL13RA1 from individuals with idiopathic Parkinson\u2019s disease increase cellular susceptibility to oxidative stress. Brain Behav Immun. 2020;88:920\u20134.","journal-title":"Brain Behav Immun"},{"issue":"5726","key":"571_CR97","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314\u20138.","journal-title":"Science"},{"key":"571_CR98","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neuroscience.2020.03.008","volume":"437","author":"Y He","year":"2020","unstructured":"He Y, Gao Y, Zhang Q, Zhou G, Cao F, Yao S. IL-4 Switches microglia\/macrophage M1\/M2 polarization and alleviates neurological damage by modulating the JAK1\/STAT6 pathway following ICH. Neuroscience. 2020;437:161\u201371.","journal-title":"Neuroscience"},{"key":"571_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.815347","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo S, Wang H, Yin Y. Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci. 2022;14:815347.","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"571_CR100","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.immuni.2022.10.016","volume":"55","author":"X Chen","year":"2022","unstructured":"Chen X, Holtzman DM. Emerging roles of innate and adaptive immunity in Alzheimer\u2019s disease. Immunity. 2022;55(12):2236\u201354.","journal-title":"Immunity"},{"issue":"21","key":"571_CR101","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110(21):3458\u201383.","journal-title":"Neuron"},{"issue":"2","key":"571_CR102","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s12264-025-01505-1","volume":"42","author":"Y Xu","year":"2026","unstructured":"Xu Y, Han T, Wu Y, Liu H, Hou K, An Z, et al. Role of microglial dysfunction in Parkinson\u2019s Disease: from multifactorial causes to neurodegeneration. Neurosci Bull. 2026;42(2):439\u201359.","journal-title":"Neurosci Bull"},{"issue":"1","key":"571_CR103","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-024-00402-3","volume":"13","author":"C Rim","year":"2024","unstructured":"Rim C, You MJ, Nahm M, Kwon MS. Emerging role of senescent microglia in brain aging-related neurodegenerative diseases. Transl Neurodegener. 2024;13(1):10.","journal-title":"Transl Neurodegener"},{"issue":"10","key":"571_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109228","volume":"35","author":"Y Hu","year":"2021","unstructured":"Hu Y, Fryatt GL, Ghorbani M, Obst J, Menassa DA, Martin-Estebane M, et al. Replicative senescence dictates the emergence of disease-associated microglia and contributes to Abeta pathology. Cell Rep. 2021;35(10):109228.","journal-title":"Cell Rep"},{"issue":"3","key":"571_CR105","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566-81 e9.","journal-title":"Immunity"},{"issue":"6","key":"571_CR106","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41593-024-01620-8","volume":"27","author":"N Rachmian","year":"2024","unstructured":"Rachmian N, Medina S, Cherqui U, Akiva H, Deitch D, Edilbi D, et al. Identification of senescent, TREM2-expressing microglia in aging and Alzheimer\u2019s disease model mouse brain. Nat Neurosci. 2024;27(6):1116\u201324.","journal-title":"Nat Neurosci"},{"issue":"20","key":"571_CR107","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","volume":"186","author":"N Sun","year":"2023","unstructured":"Sun N, Victor MB, Park YP, Xiong X, Scannail AN, Leary N, et al. Human microglial state dynamics in Alzheimer\u2019s disease progression. Cell. 2023;186(20):4386-403 e29.","journal-title":"Cell"},{"issue":"1","key":"571_CR108","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1038\/s41467-023-39060-w","volume":"14","author":"AM Schonhoff","year":"2023","unstructured":"Schonhoff AM, Figge DA, Williams GP, Jurkuvenaite A, Gallups NJ, Childers GM, et al. Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease. Nat Commun. 2023;14(1):3754.","journal-title":"Nat Commun"},{"issue":"5","key":"571_CR109","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1002\/mco2.363","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu Y, Sun J, Zhang W, Guo Z, Ma Q. Arachidonic acid metabolism in health and disease. MedComm (2020). 2023;4(5):e363.","journal-title":"MedComm (2020)"},{"key":"571_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108381","volume":"244","author":"G van Echten-Deckert","year":"2023","unstructured":"van Echten-Deckert G. The role of sphingosine 1-phosphate metabolism in brain health and disease. Pharmacol Ther. 2023;244:108381.","journal-title":"Pharmacol Ther"},{"key":"571_CR111","doi-asserted-by":"publisher","first-page":"652593","DOI":"10.3389\/fncel.2021.652593","volume":"15","author":"T Ernest James Phillips","year":"2021","unstructured":"Ernest James Phillips T, Maguire E. Phosphoinositides: roles in the development of microglial-mediated neuroinflammation and neurodegeneration. Front Cell Neurosci. 2021;15:652593.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"571_CR112","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","volume":"2","author":"R Chen","year":"2012","unstructured":"Chen R, Zhang J, Wu Y, Wang D, Feng G, Tang YP, et al. Monoacylglycerol lipase is a therapeutic target for Alzheimer\u2019s disease. Cell Rep. 2012;2(5):1329\u201339.","journal-title":"Cell Rep"},{"key":"571_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0305-9","volume":"12","author":"R Pihlaja","year":"2015","unstructured":"Pihlaja R, Takkinen J, Eskola O, Vasara J, L\u00f3pez-Pic\u00f3n FR, Haaparanta-Solin M, et al. Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells. J Neuroinflammation. 2015;12:81.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"571_CR114","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2174\/156802607780487623","volume":"7","author":"BL Nanda","year":"2007","unstructured":"Nanda BL, Nataraju A, Rajesh R, Rangappa KS, Shekar MA, Vishwanath BS. PLA2 mediated arachidonate free radicals: PLA2 inhibition and neutralization of free radicals by anti-oxidants\u2013a new role as anti-inflammatory molecule. Curr Top Med Chem. 2007;7(8):765\u201377.","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"571_CR115","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.bbalip.2018.08.010","volume":"1864","author":"VD Mouchlis","year":"2019","unstructured":"Mouchlis VD, Dennis EA. Phospholipase A(2) catalysis and lipid mediator lipidomics. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(6):766\u201371.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"2","key":"571_CR116","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainresrev.2006.02.002","volume":"52","author":"JW Phillis","year":"2006","unstructured":"Phillis JW, Horrocks LA, Farooqui AA. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev. 2006;52(2):201\u201343.","journal-title":"Brain Res Rev"},{"issue":"3","key":"571_CR117","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1523\/JNEUROSCI.5177-11.2012","volume":"32","author":"JR Sundaram","year":"2012","unstructured":"Sundaram JR, Chan ES, Poore CP, Pareek TK, Cheong WF, Shui G, et al. Cdk5\/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J Neurosci. 2012;32(3):1020\u201334.","journal-title":"J Neurosci"},{"issue":"11","key":"571_CR118","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1038\/s43587-025-00976-1","volume":"5","author":"M Gao","year":"2025","unstructured":"Gao M, Bai J, Lou F, Sun Y, Wang Z, Cai X, et al. Loss of MFE-2 impairs microglial lipid homeostasis and drives neuroinflammation in Alzheimer\u2019s pathogenesis. Nat Aging. 2025;5(11):2279\u201396.","journal-title":"Nat Aging"},{"issue":"6057","key":"571_CR119","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1126\/science.1209200","volume":"334","author":"DK Nomura","year":"2011","unstructured":"Nomura DK, Morrison BE, Blankman JL, Long JZ, Kinsey SG, Marcondes MC, et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science. 2011;334(6057):809\u201313.","journal-title":"Science"},{"key":"571_CR120","doi-asserted-by":"publisher","DOI":"10.4103\/nrr.nrr-d-25-01082","author":"R Wang","year":"2025","unstructured":"Wang R, Hatano T, Hattori N, Cossu D. Interplay of GBA1 with lysosomal dysfunction and inflammation in Parkinson\u2019s disease. Neural Regen Res.\u00a02026;21(10):4803-4812.","journal-title":"Neural Regen Res"},{"issue":"12","key":"571_CR121","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1093\/brain\/awae222","volume":"147","author":"SH Kweon","year":"2024","unstructured":"Kweon SH, Ryu HG, Kwon SH, Park H, Lee S, Kim NS, et al. Gba1 E326K renders motor and non-motor symptoms with pathological \u03b1-synuclein, tau and glial activation. Brain. 2024;147(12):4072\u201383.","journal-title":"Brain"},{"issue":"2","key":"571_CR122","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s12640-017-9798-6","volume":"33","author":"J Brodowicz","year":"2018","unstructured":"Brodowicz J, Przegali\u0144ski E, M\u00fcller CP, Filip M. Ceramide and its related neurochemical networks as targets for some brain disorder therapies. Neurotox Res. 2018;33(2):474\u201384.","journal-title":"Neurotox Res"},{"issue":"1","key":"571_CR123","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40478-023-01633-7","volume":"11","author":"SM Crivelli","year":"2023","unstructured":"Crivelli SM, Quadri Z, Vekaria HJ, Zhu Z, Tripathi P, Elsherbini A, et al. Inhibition of acid sphingomyelinase reduces reactive astrocyte secretion of mitotoxic extracellular vesicles and improves Alzheimer\u2019s disease pathology in the 5xFAD mouse. Acta Neuropathol Commun. 2023;11(1):135.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"571_CR124","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","volume":"20","author":"K Kitatani","year":"2008","unstructured":"Kitatani K, Idkowiak-Baldys J, Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008;20(6):1010\u20138.","journal-title":"Cell Signal"},{"issue":"5","key":"571_CR125","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","volume":"4","author":"S Spiegel","year":"2003","unstructured":"Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4(5):397\u2013407.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"571_CR126","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/glia.23558","volume":"67","author":"L Zhong","year":"2019","unstructured":"Zhong L, Jiang X, Zhu Z, Qin H, Dinkins MB, Kong JN, et al. Lipid transporter Spns2 promotes microglia pro-inflammatory activation in response to amyloid-beta peptide. Glia. 2019;67(3):498\u2013511.","journal-title":"Glia"},{"key":"571_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104713","volume":"94","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Zhang L, Elsherbini A, Crivelli SM, Tripathi P, Harper C, et al. The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases A\u03b2 clearance in 5XFAD mice. EBioMedicine. 2023;94:104713.","journal-title":"EBioMedicine"},{"key":"571_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1078854","volume":"15","author":"JS Schneider","year":"2022","unstructured":"Schneider JS, Singh G. Altered expression of glycobiology-related genes in Parkinson\u2019s disease brain. Front Mol Neurosci. 2022;15:1078854.","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"571_CR129","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.freeradbiomed.2006.12.003","volume":"42","author":"S Hashioka","year":"2007","unstructured":"Hashioka S, Han YH, Fujii S, Kato T, Monji A, Utsumi H, et al. Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid beta and interferon-gamma-induced microglial activation. Free Radic Biol Med. 2007;42(7):945\u201354.","journal-title":"Free Radic Biol Med"},{"issue":"6512","key":"571_CR130","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.abb8587","volume":"370","author":"T Bartels","year":"2020","unstructured":"Bartels T, De Schepper S, Hong S. Microglia modulate neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases. Science. 2020;370(6512):66\u20139.","journal-title":"Science"},{"issue":"1","key":"571_CR131","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40035-023-00382-w","volume":"12","author":"I Lepiarz-Raba","year":"2023","unstructured":"Lepiarz-Raba I, Gbadamosi I, Florea R, Paolicelli RC, Jawaid A. Metabolic regulation of microglial phagocytosis: implications for Alzheimer\u2019s disease therapeutics. Transl Neurodegener. 2023;12(1):48.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"571_CR132","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0006-8993(95)01407-1","volume":"712","author":"WA Jefferies","year":"1996","unstructured":"Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, Yasuhara O, et al. Reactive microglia specifically associated with amyloid plaques in Alzheimer\u2019s disease brain tissue express melanotransferrin. Brain Res. 1996;712(1):122\u20136.","journal-title":"Brain Res"},{"issue":"8","key":"571_CR133","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38(8):1285\u201391.","journal-title":"Neurology"},{"issue":"17","key":"571_CR134","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/cells11172728","volume":"11","author":"G Di Benedetto","year":"2022","unstructured":"Di Benedetto G, Burgaletto C, Bellanca CM, Munafo A, Bernardini R, Cantarella G. Role of microglia and astrocytes in Alzheimer\u2019s disease: from neuroinflammation to Ca(2+) homeostasis dysregulation. Cells. 2022;11(17):2728.","journal-title":"Cells"},{"issue":"1","key":"571_CR135","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1189\/jlb.3MR0416-204R","volume":"101","author":"C Venegas","year":"2017","unstructured":"Venegas C, Heneka MT. Danger-associated molecular patterns in Alzheimer\u2019s disease. J Leukoc Biol. 2017;101(1):87\u201398.","journal-title":"J Leukoc Biol"},{"key":"571_CR136","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-2094-5-23","volume":"5","author":"JJ Jin","year":"2008","unstructured":"Jin JJ, Kim HD, Maxwell JA, Li L, Fukuchi K. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer\u2019s disease. J Neuroinflammation. 2008;5:23.","journal-title":"J Neuroinflammation"},{"issue":"Pt 11","key":"571_CR137","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1093\/brain\/awl249","volume":"129","author":"K Tahara","year":"2006","unstructured":"Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain. 2006;129(Pt 11):3006\u201319.","journal-title":"Brain"},{"issue":"7434","key":"571_CR138","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493(7434):674\u20138.","journal-title":"Nature"},{"issue":"4","key":"571_CR139","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1172\/JCI2029","volume":"102","author":"JB Mackic","year":"1998","unstructured":"Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, Kim KS, et al. Human blood-brain barrier receptors for Alzheimer\u2019s amyloid-beta 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest. 1998;102(4):734\u201343.","journal-title":"J Clin Invest"},{"issue":"6593","key":"571_CR140","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease. Nature. 1996;382(6593):685\u201391.","journal-title":"Nature"},{"issue":"14","key":"571_CR141","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1096\/fj.05-4578fje","volume":"19","author":"P Iribarren","year":"2005","unstructured":"Iribarren P, Chen K, Hu J, Gong W, Cho EH, Lockett S, et al. CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1\u201342 peptide by up-regulating the expression of the G-protein- coupled receptor mFPR2. FASEB J. 2005;19(14):2032\u20134.","journal-title":"FASEB J"},{"issue":"Pt 8","key":"571_CR142","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/brain\/awh531","volume":"128","author":"Y Liu","year":"2005","unstructured":"Liu Y, Walter S, Stagi M, Cherny D, Letiembre M, Schulz-Schaeffer W, et al. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer\u2019s amyloid peptide. Brain. 2005;128(Pt 8):1778\u201389.","journal-title":"Brain"},{"key":"571_CR143","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2147\/ITT.S305420","volume":"10","author":"A Gomez-Arboledas","year":"2021","unstructured":"Gomez-Arboledas A, Acharya MM, Tenner AJ. The role of complement in synaptic pruning and neurodegeneration. Immunotargets Ther. 2021;10:373\u201386.","journal-title":"Immunotargets Ther"},{"issue":"8","key":"571_CR144","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1111\/febs.15772","volume":"289","author":"O Fatoba","year":"2022","unstructured":"Fatoba O, Itokazu T, Yamashita T. Complement cascade functions during brain development and neurodegeneration. FEBS J. 2022;289(8):2085\u2013109.","journal-title":"FEBS J"},{"issue":"6286","key":"571_CR145","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712\u20136.","journal-title":"Science"},{"key":"571_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109646","volume":"237","author":"X Wu","year":"2023","unstructured":"Wu X, Gao Y, Shi C, Tong J, Ma D, Shen J, et al. Complement C1q drives microglia-dependent synaptic loss and cognitive impairments in a mouse model of lipopolysaccharide-induced neuroinflammation. Neuropharmacology. 2023;237:109646.","journal-title":"Neuropharmacology"},{"issue":"1","key":"571_CR147","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12974-022-02539-2","volume":"19","author":"K Carvalho","year":"2022","unstructured":"Carvalho K, Schartz ND, Balderrama-Gutierrez G, Liang HY, Chu SH, Selvan P, et al. Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression. J Neuroinflammation. 2022;19(1):178.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"571_CR148","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40478-022-01416-6","volume":"10","author":"A Gomez-Arboledas","year":"2022","unstructured":"Gomez-Arboledas A, Carvalho K, Balderrama-Gutierrez G, Chu SH, Liang HY, Schartz ND, et al. C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2022;10(1):116.","journal-title":"Acta Neuropathol Commun"},{"key":"571_CR149","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, et al. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 2013;4:1562.","journal-title":"Nat Commun"},{"key":"571_CR150","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.redox.2017.11.010","volume":"14","author":"L Hou","year":"2018","unstructured":"Hou L, Bao X, Zang C, Yang H, Sun F, Che Y, et al. Integrin CD11b mediates alpha-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway. Redox Biol. 2018;14:600\u20138.","journal-title":"Redox Biol"},{"key":"571_CR151","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-981-13-9913-8_13","volume":"1175","author":"MS Ho","year":"2019","unstructured":"Ho MS. Microglia in Parkinson\u2019s Disease. Adv Exp Med Biol. 2019;1175:335\u201353.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"571_CR152","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/eji.201848013","volume":"50","author":"T Suzuki","year":"2020","unstructured":"Suzuki T, Kohyama K, Moriyama K, Ozaki M, Hasegawa S, Ueno T, et al. Extracellular ADP augments microglial inflammasome and NF-kappaB activation via the P2Y12 receptor. Eur J Immunol. 2020;50(2):205\u201319.","journal-title":"Eur J Immunol"},{"issue":"6","key":"571_CR153","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918\u201334.","journal-title":"Cell"},{"issue":"1","key":"571_CR154","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12974-019-1603-4","volume":"16","author":"F Jing","year":"2019","unstructured":"Jing F, Zhang Y, Long T, He W, Qin G, Zhang D, et al. P2Y12 receptor mediates microglial activation via RhoA\/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine. J Neuroinflammation. 2019;16(1):217.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"571_CR155","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21(9):548\u201369.","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"571_CR156","doi-asserted-by":"publisher","first-page":"R730","DOI":"10.1016\/j.cub.2022.05.027","volume":"32","author":"Z Sun","year":"2022","unstructured":"Sun Z, Hornung V. cGAS-STING signaling. Curr Biol. 2022;32(13):R730\u20134.","journal-title":"Curr Biol"},{"issue":"8","key":"571_CR157","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","volume":"33","author":"C Chen","year":"2023","unstructured":"Chen C, Xu P. Cellular functions of cGAS-STING signaling. Trends Cell Biol. 2023;33(8):630\u201348.","journal-title":"Trends Cell Biol"},{"issue":"12","key":"571_CR158","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS-STING pathway and cancer. Nat Cancer. 2022;3(12):1452\u201363.","journal-title":"Nat Cancer"},{"issue":"9","key":"571_CR159","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s12276-024-01295-y","volume":"56","author":"S Chung","year":"2024","unstructured":"Chung S, Jeong JH, Park JC, Han JW, Lee Y, Kim JI, et al. Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u2019s disease pathologies. Exp Mol Med. 2024;56(9):1936\u201351.","journal-title":"Exp Mol Med"},{"issue":"2","key":"571_CR160","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","volume":"3","author":"X Xie","year":"2023","unstructured":"Xie X, Ma G, Li X, Zhao J, Zhao Z, Zeng J. Activation of innate immune cGAS-STING pathway contributes to Alzheimer\u2019s pathogenesis in 5xFAD mice. Nat Aging. 2023;3(2):202\u201312.","journal-title":"Nat Aging"},{"issue":"12","key":"571_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410910","volume":"12","author":"S He","year":"2025","unstructured":"He S, Li X, Mittra N, Bhattacharjee A, Wang H, Song S, et al. Microglial cGAS deletion preserves intercellular communication and alleviates amyloid-beta-induced pathogenesis of Alzheimer\u2019s disease. Adv Sci (Weinh). 2025;12(12):e2410910.","journal-title":"Adv Sci (Weinh)"},{"issue":"23","key":"571_CR162","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1016\/j.neuron.2024.09.006","volume":"112","author":"GK Carling","year":"2024","unstructured":"Carling GK, Fan L, Foxe NR, Norman K, Ye P, Wong MY, et al. Alzheimer\u2019s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model. Neuron. 2024;112(23):3877\u201396.","journal-title":"Neuron"},{"issue":"7","key":"571_CR163","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1111\/cns.14157","volume":"29","author":"C Ma","year":"2023","unstructured":"Ma C, Liu Y, Li S, Ma C, Huang J, Wen S, et al. Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson\u2019s disease. CNS Neurosci Ther. 2023;29(7):2018\u201335.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"571_CR164","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12974-025-03396-5","volume":"22","author":"Y Lu","year":"2025","unstructured":"Lu Y, Gao L, Yang Y, Shi D, Zhang Z, Wang X, et al. Protective role of mitophagy on microglia-mediated neuroinflammatory injury through mtDNA-STING signaling in manganese-induced parkinsonism. J Neuroinflammation. 2025;22(1):55.","journal-title":"J Neuroinflammation"},{"key":"571_CR165","doi-asserted-by":"publisher","first-page":"13348","DOI":"10.1038\/ncomms13348","volume":"7","author":"LS Reinert","year":"2016","unstructured":"Reinert LS, Lopusna K, Winther H, Sun C, Thomsen MK, Nandakumar R, et al. Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS. Nat Commun. 2016;7:13348.","journal-title":"Nat Commun"},{"key":"571_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109206","volume":"217","author":"W Wu","year":"2022","unstructured":"Wu W, Zhang X, Wang S, Li T, Hao Q, Li S, et al. Pharmacological inhibition of the cGAS-STING signaling pathway suppresses microglial M1-polarization in the spinal cord and attenuates neuropathic pain. Neuropharmacology. 2022;217:109206.","journal-title":"Neuropharmacology"},{"issue":"1","key":"571_CR167","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89(1):37\u201353.","journal-title":"Neuron"},{"key":"571_CR168","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-9068-9_1","volume":"1938","author":"U Hasan","year":"2019","unstructured":"Hasan U, Singh SK. The astrocyte-neuron interface: An overview on molecular and cellular dynamics controlling formation and maintenance of the tripartite synapse. Methods Mol Biol. 2019;1938:3\u201318.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"571_CR169","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41593-018-0325-8","volume":"22","author":"M Santello","year":"2019","unstructured":"Santello M, Toni N, Volterra A. Astrocyte function from information processing to cognition and cognitive impairment. Nat Neurosci. 2019;22(2):154\u201366.","journal-title":"Nat Neurosci"},{"issue":"3","key":"571_CR170","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2017.09.056","volume":"96","author":"NJ Allen","year":"2017","unstructured":"Allen NJ, Eroglu C. Cell biology of astrocyte-synapse interactions. Neuron. 2017;96(3):697\u2013708.","journal-title":"Neuron"},{"issue":"1","key":"571_CR171","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41467-022-29475-2","volume":"13","author":"WA Mills 3rd","year":"2022","unstructured":"Mills WA 3rd, Woo AM, Jiang S, Martin J, Surendran D, Bergstresser M, et al. Astrocyte plasticity in mice ensures continued endfoot coverage of cerebral blood vessels following injury and declines with age. Nat Commun. 2022;13(1):1794.","journal-title":"Nat Commun"},{"issue":"1","key":"571_CR172","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02428-8","volume":"19","author":"X Fei","year":"2022","unstructured":"Fei X, Dou YN, Wang L, Wu X, Huan Y, Wu S, et al. Homer1 promotes the conversion of A1 astrocytes to A2 astrocytes and improves the recovery of transgenic mice after intracerebral hemorrhage. J Neuroinflammation. 2022;19(1):67.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"571_CR173","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation. 2022;19(1):206.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"571_CR174","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1440-1827.1998.tb03915.x","volume":"48","author":"S Kato","year":"1998","unstructured":"Kato S, Gondo T, Hoshii Y, Takahashi M, Yamada M, Ishihara T. Confocal observation of senile plaques in Alzheimer\u2019s disease: senile plaque morphology and relationship between senile plaques and astrocytes. Pathol Int. 1998;48(5):332\u201340.","journal-title":"Pathol Int"},{"issue":"1","key":"571_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","volume":"52","author":"P Damier","year":"1993","unstructured":"Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson\u2019s disease. Neuroscience. 1993;52(1):1\u20136.","journal-title":"Neuroscience"},{"issue":"3","key":"571_CR176","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1353-8020(99)00022-X","volume":"5","author":"C Knott","year":"1999","unstructured":"Knott C, Wilkin GP, Stern G. Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson\u2019s disease. Parkinsonism Relat Disord. 1999;5(3):115\u201322.","journal-title":"Parkinsonism Relat Disord"},{"key":"571_CR177","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1742-2094-8-150","volume":"8","author":"J Zhao","year":"2011","unstructured":"Zhao J, O\u2019Connor T, Vassar R. The contribution of activated astrocytes to Abeta production: implications for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation. 2011;8:150.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"571_CR178","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1474-9726.2011.00685.x","volume":"10","author":"AY Abramov","year":"2011","unstructured":"Abramov AY, Ionov M, Pavlov E, Duchen MR. Membrane cholesterol content plays a key role in the neurotoxicity of beta-amyloid: implications for Alzheimer\u2019s disease. Aging Cell. 2011;10(4):595\u2013603.","journal-title":"Aging Cell"},{"issue":"2","key":"571_CR179","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1523\/JNEUROSCI.4042-03.2004","volume":"24","author":"AY Abramov","year":"2004","unstructured":"Abramov AY, Canevari L, Duchen MR. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci. 2004;24(2):565\u201375.","journal-title":"J Neurosci"},{"issue":"6483","key":"571_CR180","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/369744a0","volume":"369","author":"V Parpura","year":"1994","unstructured":"Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG. Glutamate-mediated astrocyte-neuron signalling. Nature. 1994;369(6483):744\u20137.","journal-title":"Nature"},{"issue":"4","key":"571_CR181","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nm838","volume":"9","author":"T Wyss-Coray","year":"2003","unstructured":"Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med. 2003;9(4):453\u20137.","journal-title":"Nat Med"},{"issue":"25","key":"571_CR182","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1523\/JNEUROSCI.0877-17.2017","volume":"37","author":"P Sompol","year":"2017","unstructured":"Sompol P, Furman JL, Pleiss MM, Kraner SD, Artiushin IA, Batten SR, et al. Calcineurin\/NFAT signaling in activated astrocytes drives network hyperexcitability in Abeta-bearing mice. J Neurosci. 2017;37(25):6132\u201348.","journal-title":"J Neurosci"},{"issue":"6","key":"571_CR183","doi-asserted-by":"publisher","first-page":"8223","DOI":"10.3892\/mmr.2017.7670","volume":"16","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Jiang P, Li W, Liu X, Lu Y, Huang Z, et al. Calcineurin\/NFAT signaling pathway mediates titanium particle\u2011induced inflammation and osteoclast formation by inhibiting RANKL and M\u2011CSF in vitro. Mol Med Rep. 2017;16(6):8223\u201330.","journal-title":"Mol Med Rep"},{"issue":"2","key":"571_CR184","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/cells9020383","volume":"9","author":"YN Paudel","year":"2020","unstructured":"Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh MF. Impact of HMGB1, RAGE, and TLR4 in Alzheimer\u2019s disease (AD): from risk factors to therapeutic targeting. Cells. 2020;9(2):383.","journal-title":"Cells"},{"key":"571_CR185","doi-asserted-by":"crossref","unstructured":"Wang J, Chen Z, Walston JD, Gao P, Gao M, Leng SX. alpha-Synuclein activates innate immunity but suppresses interferon-gamma expression in murine astrocytes. Eur J Neurosci. 2018.","DOI":"10.1111\/ejn.13956"},{"issue":"5","key":"571_CR186","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron. 2017;96(5):1024-32 e3.","journal-title":"Neuron"},{"key":"571_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00114","volume":"10","author":"BG Perez-Nievas","year":"2018","unstructured":"Perez-Nievas BG, Serrano-Pozo A. Deciphering the astrocyte reaction in Alzheimer\u2019s disease. Front Aging Neurosci. 2018;10:114.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"571_CR188","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-019-1436-1","volume":"16","author":"NM de Wit","year":"2019","unstructured":"de Wit NM, den Hoedt S, Martinez-Martinez P, Rozemuller AJ, Mulder MT, de Vries HE. Astrocytic ceramide as possible indicator of neuroinflammation. J Neuroinflammation. 2019;16(1):48.","journal-title":"J Neuroinflammation"},{"issue":"25","key":"571_CR189","doi-asserted-by":"publisher","first-page":"21384","DOI":"10.1074\/jbc.M112.340513","volume":"287","author":"G Wang","year":"2012","unstructured":"Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A, et al. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem. 2012;287(25):21384\u201395.","journal-title":"J Biol Chem"},{"issue":"2","key":"571_CR190","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1471-4159.1991.tb08180.x","volume":"56","author":"SA Moore","year":"1991","unstructured":"Moore SA, Yoder E, Murphy S, Dutton GR, Spector AA. Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J Neurochem. 1991;56(2):518\u201324.","journal-title":"J Neurochem"},{"issue":"2\u20133","key":"571_CR191","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1385\/JMN:16:2-3:195","volume":"16","author":"SA Moore","year":"2001","unstructured":"Moore SA. Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J Mol Neurosci. 2001;16(2\u20133):195\u2013200 (discussion 15\u201321).","journal-title":"J Mol Neurosci"},{"issue":"9","key":"571_CR192","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/S0022-2275(20)30268-6","volume":"42","author":"DE Williard","year":"2001","unstructured":"Williard DE, Harmon SD, Kaduce TL, Preuss M, Moore SA, Robbins ME, et al. Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. J Lipid Res. 2001;42(9):1368\u201376.","journal-title":"J Lipid Res"},{"issue":"12","key":"571_CR193","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3945\/jn.108.096016","volume":"138","author":"WJ Lukiw","year":"2008","unstructured":"Lukiw WJ, Bazan NG. Docosahexaenoic acid and the aging brain. J Nutr. 2008;138(12):2510\u20134.","journal-title":"J Nutr"},{"issue":"10","key":"571_CR194","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2174\/011570159X365720250225080257","volume":"23","author":"B Zia","year":"2025","unstructured":"Zia B, Elmeky M, Azimullah S, Jha NK, Nagoor Meeran MF, Ojha SK. The multifaceted role of neuroprotectin D1: physiological, pathophysiological, and pharmacological insights in neurodegenerative diseases. Curr Neuropharmacol. 2025;23(10):1215\u201331.","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"571_CR195","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10571-015-0206-6","volume":"35","author":"JM Calandria","year":"2015","unstructured":"Calandria JM, Sharp MW, Bazan NG. The docosanoid neuroprotectin D1 induces TH-positive neuronal survival in a cellular model of Parkinson\u2019s disease. Cell Mol Neurobiol. 2015;35(8):1127\u201336.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"571_CR196","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12868-021-00611-w","volume":"22","author":"E Zg\u00f3rzy\u0144ska","year":"2021","unstructured":"Zg\u00f3rzy\u0144ska E, Stulczewski D, Dziedzic B, Su KP, Walczewska A. Docosahexaenoic fatty acid reduces the pro-inflammatory response induced by IL-1\u03b2 in astrocytes through inhibition of NF-\u03baB and AP-1 transcription factor activation. BMC Neurosci. 2021;22(1):4.","journal-title":"BMC Neurosci"},{"issue":"1","key":"571_CR197","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41380-020-00930-0","volume":"26","author":"B Zhou","year":"2021","unstructured":"Zhou B, Zhu Z, Ransom BR, Tong X. Oligodendrocyte lineage cells and depression. Mol Psychiatry. 2021;26(1):103\u201317.","journal-title":"Mol Psychiatry"},{"key":"571_CR198","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nbd.2016.01.017","volume":"89","author":"AR Hackett","year":"2016","unstructured":"Hackett AR, Lee DH, Dawood A, Rodriguez M, Funk L, Tsoulfas P, et al. STAT3 and SOCS3 regulate NG2 cell proliferation and differentiation after contusive spinal cord injury. Neurobiol Dis. 2016;89:10\u201322.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"571_CR199","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1038\/s41467-021-25956-y","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liu Y, Hong X, Li X, Meshul CK, Moore C, et al. NG2 glia-derived GABA release tunes inhibitory synapses and contributes to stress-induced anxiety. Nat Commun. 2021;12(1):5740.","journal-title":"Nat Commun"},{"issue":"1","key":"571_CR200","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00441-020-03195-9","volume":"381","author":"R Li","year":"2020","unstructured":"Li R, Zhang P, Zhang M, Yao Z. The roles of neuron-NG2 glia synapses in promoting oligodendrocyte development and remyelination. Cell Tissue Res. 2020;381(1):43\u201353.","journal-title":"Cell Tissue Res"},{"key":"571_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113720","volume":"171","author":"F Li","year":"2020","unstructured":"Li F, Liu WC, Wang Q, Sun Y, Wang H, Jin X. NG2-glia cell proliferation and differentiation by glial growth factor 2 (GGF2), a strategy to promote functional recovery after ischemic stroke. Biochem Pharmacol. 2020;171:113720.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"571_CR202","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smajic","year":"2022","unstructured":"Smajic S, Prada-Medina CA, Landoulsi Z, Ghelfi J, Delcambre S, Dietrich C, et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain. 2022;145(3):964\u201378.","journal-title":"Brain"},{"issue":"5","key":"571_CR203","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s12264-025-01572-4","volume":"42","author":"AO Sasmita","year":"2026","unstructured":"Sasmita AO, Depp C. A question of origins: Non-neuronal sources of amyloid-beta. Neurosci Bull. 2026;42(5):1126\u201350.","journal-title":"Neurosci Bull"},{"issue":"4","key":"571_CR204","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4161\/cam.28802","volume":"8","author":"DE Xu","year":"2014","unstructured":"Xu DE, Zhang WM, Yang ZZ, Zhu HM, Yan K, Li S, et al. Amyloid precursor protein at node of Ranvier modulates nodal formation. Cell Adhes Migr. 2014;8(4):396\u2013403.","journal-title":"Cell Adhes Migr"},{"issue":"4","key":"571_CR205","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4067\/S0716-97602005000400011","volume":"38","author":"AD Roth","year":"2005","unstructured":"Roth AD, Ramirez G, Alarcon R, Von Bernhardi R. Oligodendrocytes damage in Alzheimer\u2019s disease: beta amyloid toxicity and inflammation. Biol Res. 2005;38(4):381\u20137.","journal-title":"Biol Res"},{"issue":"4","key":"571_CR206","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","volume":"182","author":"WT Chen","year":"2020","unstructured":"Chen WT, Lu A, Craessaerts K, Pavie B, Sala Frigerio C, Corthout N, et al. Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease. Cell. 2020;182(4):976-91 e19.","journal-title":"Cell"},{"key":"571_CR207","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-981-13-9913-8_12","volume":"1175","author":"AM Butt","year":"2019","unstructured":"Butt AM, De La Rocha IC, Rivera A. Oligodendroglial cells in Alzheimer\u2019s disease. Adv Exp Med Biol. 2019;1175:325\u201333.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"571_CR208","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/neup.12395","volume":"37","author":"Y Honjo","year":"2017","unstructured":"Honjo Y, Ayaki T, Tomiyama T, Horibe T, Ito H, Mori H, et al. Decreased levels of PDI and P5 in oligodendrocytes in Alzheimer\u2019s disease. Neuropathology. 2017;37(6):495\u2013501.","journal-title":"Neuropathology"},{"key":"571_CR209","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijid.2022.11.010","volume":"126","author":"NC Wang","year":"2023","unstructured":"Wang NC, Chen HW, Lin TY. Association of protein disulfide isomerase family A, member 4, and inflammation in people living with HIV. Int J Infect Dis. 2023;126:79\u201386.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"571_CR210","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.neuron.2022.03.008","volume":"110","author":"JS Sadick","year":"2022","unstructured":"Sadick JS, O\u2019Dea MR, Hasel P, Dykstra T, Faustin A, Liddelow SA. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer\u2019s disease. Neuron. 2022;110(11):1788-805 e10.","journal-title":"Neuron"},{"issue":"1","key":"571_CR211","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41467-023-36519-8","volume":"14","author":"H Park","year":"2023","unstructured":"Park H, Cho B, Kim H, Saito T, Saido TC, Won KJ, et al. Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice. Nat Commun. 2023;14(1):802.","journal-title":"Nat Commun"},{"issue":"8","key":"571_CR212","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41588-021-00894-z","volume":"53","author":"S Morabito","year":"2021","unstructured":"Morabito S, Miyoshi E, Michael N, Shahin S, Martini AC, Head E, et al. Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer\u2019s disease. Nat Genet. 2021;53(8):1143\u201355.","journal-title":"Nat Genet"},{"issue":"7937","key":"571_CR213","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;611(7937):769\u201379.","journal-title":"Nature"},{"issue":"6","key":"571_CR214","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/glia.23974","volume":"69","author":"MF Lanfranco","year":"2021","unstructured":"Lanfranco MF, Sepulveda J, Kopetsky G, Rebeck GW. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia. 2021;69(6):1478\u201393.","journal-title":"Glia"},{"issue":"6","key":"571_CR215","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s12640-020-00271-4","volume":"39","author":"MS Uddin","year":"2021","unstructured":"Uddin MS, Kabir MT, Begum MM, Islam MS, Behl T, Ashraf MGM. Exploring the role of CLU in the pathogenesis of Alzheimer\u2019s disease. Neurotox Res. 2021;39(6):2108\u201319.","journal-title":"Neurotox Res"},{"key":"571_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106729","author":"BY Zhang","year":"2020","unstructured":"Zhang BY, Zhao J, Wang Z, Xu LJ, Liu AL, Du GH. DL0410 attenuates oxidative stress and neuroinflammation via BDNF\/TrkB\/ERK\/CREB and Nrf2\/HO-1 activation. Int Immunopharmacol.\u00a02020:86:106729.","journal-title":"Int Immunopharmacol"},{"issue":"7761","key":"571_CR217","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature. 2019;570(7761):332\u20137.","journal-title":"Nature"},{"issue":"1","key":"571_CR218","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.bbrc.2018.11.024","volume":"508","author":"YS Guo","year":"2019","unstructured":"Guo YS, Liang PZ, Lu SZ, Chen R, Yin YQ, Zhou JW. Extracellular alphaB-crystallin modulates the inflammatory responses. Biochem Biophys Res Commun. 2019;508(1):282\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7435","key":"571_CR219","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature11748","volume":"494","author":"W Shao","year":"2013","unstructured":"Shao W, Zhang SZ, Tang M, Zhang XH, Zhou Z, Yin YQ, et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin. Nature. 2013;494(7435):90\u20134.","journal-title":"Nature"},{"issue":"49","key":"571_CR220","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb8680","volume":"6","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang R, Hu D, Sun X, Fujioka H, Lundberg K, et al. Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer\u2019s disease. Sci Adv. 2020;6(49):eabb8680.","journal-title":"Sci Adv"},{"issue":"1","key":"571_CR221","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1038\/s41467-020-17876-0","volume":"11","author":"D Agarwal","year":"2020","unstructured":"Agarwal D, Sandor C, Volpato V, Caffrey TM, Monzon-Sandoval J, Bowden R, et al. A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders. Nat Commun. 2020;11(1):4183.","journal-title":"Nat Commun"},{"issue":"4","key":"571_CR222","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3233\/JPD-160881","volume":"6","author":"Z Kurowska","year":"2016","unstructured":"Kurowska Z, Kordower JH, Stoessl AJ, Burke RE, Brundin P, Yue Z, et al. Is axonal degeneration a key early event in Parkinson\u2019s disease? J Parkinsons Dis. 2016;6(4):703\u20137.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"571_CR223","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12916-019-1439-x","volume":"17","author":"SZ Zhang","year":"2019","unstructured":"Zhang SZ, Wang QQ, Yang QQ, Gu HY, Yin YQ, Li YD, et al. NG2 glia regulate brain innate immunity via TGF-beta2\/TGFBR2 axis. BMC Med. 2019;17(1):204.","journal-title":"BMC Med"},{"issue":"3","key":"571_CR224","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/glia.20121","volume":"49","author":"G Alonso","year":"2005","unstructured":"Alonso G. NG2 proteoglycan-expressing cells of the adult rat brain: possible involvement in the formation of glial scar astrocytes following stab wound. Glia. 2005;49(3):318\u201338.","journal-title":"Glia"},{"issue":"7","key":"571_CR225","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/cns.12690","volume":"23","author":"FE Song","year":"2017","unstructured":"Song FE, Huang JL, Lin SH, Wang S, Ma GF, Tong XP. Roles of NG2-glia in ischemic stroke. CNS Neurosci Ther. 2017;23(7):547\u201353.","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"571_CR226","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler RG, Zhang S, et al. Senolytic therapy alleviates Abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nat Neurosci. 2019;22(5):719\u201328.","journal-title":"Nat Neurosci"},{"issue":"1","key":"571_CR227","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2051-5960-1-7","volume":"1","author":"HM Nielsen","year":"2013","unstructured":"Nielsen HM, Ek D, Avdic U, Orbjorn C, Hansson O, Netherlands Brain B, et al. NG2 cells, a new trail for Alzheimer\u2019s disease mechanisms? Acta Neuropathol Commun. 2013;1(1):7.","journal-title":"Acta Neuropathol Commun"},{"issue":"14","key":"571_CR228","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/glia.21040","volume":"58","author":"Y Kitamura","year":"2010","unstructured":"Kitamura Y, Inden M, Minamino H, Abe M, Takata K, Taniguchi T. The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigra. Glia. 2010;58(14):1686\u2013700.","journal-title":"Glia"},{"key":"571_CR229","doi-asserted-by":"publisher","first-page":"175909142311559","DOI":"10.1177\/17590914231155976","volume":"15","author":"GC Nascimento","year":"2023","unstructured":"Nascimento GC, Bortolanza M, Bribian A, Leal-Luiz GC, Raisman-Vozari R, Lopez-Mascaraque L, et al. Dynamic involvement of striatal NG2-glia in L-DOPA induced dyskinesia in parkinsonian rats: effects of doxycycline. ASN Neuro. 2023;15:17590914231155976.","journal-title":"ASN Neuro"},{"issue":"9","key":"571_CR230","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1111\/jcmm.12343","volume":"18","author":"L Malmsten","year":"2014","unstructured":"Malmsten L, Vijayaraghavan S, Hovatta O, Marutle A, Darreh-Shori T. Fibrillar beta-amyloid 1\u201342 alters cytokine secretion, cholinergic signalling and neuronal differentiation. J Cell Mol Med. 2014;18(9):1874\u201388.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"571_CR231","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cmet.2024.03.014","volume":"36","author":"Y Li","year":"2024","unstructured":"Li Y, Munoz-Mayorga D, Nie Y, Kang N, Tao Y, Lagerwall J, et al. Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK. Cell Metab. 2024;36(6):1351-70 e8.","journal-title":"Cell Metab"},{"issue":"12","key":"571_CR232","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.1073\/pnas.1914593117","volume":"117","author":"LA Welikovitch","year":"2020","unstructured":"Welikovitch LA, Do Carmo S, Magloczky Z, Malcolm JC, Loke J, Klein WL, et al. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain. Proc Natl Acad Sci USA. 2020;117(12):6844\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"571_CR233","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbi.2024.08.015","volume":"122","author":"V Sigutova","year":"2024","unstructured":"Sigutova V, Xiang W, Regensburger M, Winner B, Prots I. Alpha-synuclein fine-tunes neuronal response to pro-inflammatory cytokines. Brain Behav Immun. 2024;122:216\u201330.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"571_CR234","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12951-024-02587-1","volume":"22","author":"T Lei","year":"2024","unstructured":"Lei T, Li C, Liu Y, Cui Z, Deng S, Cao J, et al. Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson\u2019s disease. J Nanobiotechnology. 2024;22(1):370.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"571_CR235","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12974-025-03506-3","volume":"22","author":"B Li","year":"2025","unstructured":"Li B, Wang L, Xiao Y, Tang Z, Wang Y, Sun T, et al. Modulation of neuronal alpha1-adrenergic receptor reduces tauopathy and neuroinflammation by inhibiting the STING\/NF-kappaB\/NLRP3 signaling pathway in Alzheimer\u2019s disease mice. J Neuroinflammation. 2025;22(1):187.","journal-title":"J Neuroinflammation"},{"issue":"28","key":"571_CR236","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202503579","volume":"12","author":"N Song","year":"2025","unstructured":"Song N, Wang X, Ha L, Hu L, Mei S, Liang Y, et al. Neuronal FGF13 inhibits mitochondria-derived damage signals to prevent neuroinflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Adv Sci (Weinh). 2025;12(28):e2503579.","journal-title":"Adv Sci (Weinh)"},{"key":"571_CR237","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.975176","volume":"14","author":"X Ma","year":"2022","unstructured":"Ma X, Li X, Wang W, Zhang M, Yang B, Miao Z. Phosphatidylserine, inflammation, and central nervous system diseases. Front Aging Neurosci. 2022;14:975176.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"571_CR238","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S1357-2725(97)00125-8","volume":"30","author":"FM Corrigan","year":"1998","unstructured":"Corrigan FM, Horrobin DF, Skinner ER, Besson JA, Cooper MB. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer\u2019s disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol. 1998;30(2):197\u2013207.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"571_CR239","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13050508","volume":"13","author":"X Bradford","year":"2024","unstructured":"Bradford X, Fernandes HJR, Snowden SG. Changes in oxidised phospholipids in response to oxidative stress in microtubule-associated protein tau (MAPT) mutant dopamine neurons. Antioxidants (Basel). 2024;13(5):508.","journal-title":"Antioxidants (Basel)"},{"key":"571_CR240","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.semcdb.2019.05.017","volume":"94","author":"S Marinelli","year":"2019","unstructured":"Marinelli S, Basilico B, Marrone MC, Ragozzino D. Microglia-neuron crosstalk: signaling mechanism and control of synaptic transmission. Semin Cell Dev Biol. 2019;94:138\u201351.","journal-title":"Semin Cell Dev Biol"},{"key":"571_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105766","volume":"170","author":"RE Henn","year":"2022","unstructured":"Henn RE, Noureldein MH, Elzinga SE, Kim B, Savelieff MG, Feldman EL. Glial-neuron crosstalk in health and disease: a focus on metabolism, obesity, and cognitive impairment. Neurobiol Dis. 2022;170:105766.","journal-title":"Neurobiol Dis"},{"key":"571_CR242","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-319-45096-4_8","volume":"13","author":"R Leke","year":"2016","unstructured":"Leke R, Schousboe A. The glutamine transporters and their role in the glutamate\/GABA-glutamine cycle. Adv Neurobiol. 2016;13:223\u201357.","journal-title":"Adv Neurobiol"},{"key":"571_CR243","doi-asserted-by":"publisher","first-page":"32422","DOI":"10.1038\/srep32422","volume":"6","author":"T Pfeiffer","year":"2016","unstructured":"Pfeiffer T, Avignone E, Nagerl UV. Induction of hippocampal long-term potentiation increases the morphological dynamics of microglial processes and prolongs their contacts with dendritic spines. Sci Rep. 2016;6:32422.","journal-title":"Sci Rep"},{"issue":"11","key":"571_CR244","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1523\/JNEUROSCI.2061-14.2015","volume":"35","author":"AK Clark","year":"2015","unstructured":"Clark AK, Gruber-Schoffnegger D, Drdla-Schutting R, Gerhold KJ, Malcangio M, Sandkuhler J. Selective activation of microglia facilitates synaptic strength. J Neurosci. 2015;35(11):4552\u201370.","journal-title":"J Neurosci"},{"key":"571_CR245","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2018.10.030","volume":"405","author":"G Manich","year":"2019","unstructured":"Manich G, Recasens M, Valente T, Almolda B, Gonzalez B, Castellano B. Role of the CD200-CD200R axis during homeostasis and neuroinflammation. Neuroscience. 2019;405:118\u201336.","journal-title":"Neuroscience"},{"issue":"6","key":"571_CR246","doi-asserted-by":"publisher","first-page":"G1081","DOI":"10.1152\/ajpgi.00123.2021","volume":"320","author":"T Yuan","year":"2021","unstructured":"Yuan T, Orock A, Greenwood-Van Meerveld B. Amygdala microglia modify neuronal plasticity via complement C1q\/C3-CR3 signaling and contribute to visceral pain in a rat model. Am J Physiol Gastrointest Liver Physiol. 2021;320(6):G1081\u201392.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"571_CR247","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/89490","volume":"4","author":"P Bezzi","year":"2001","unstructured":"Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci. 2001;4(7):702\u201310.","journal-title":"Nat Neurosci"},{"key":"571_CR248","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2018.01.059","volume":"405","author":"E Simon","year":"2019","unstructured":"Simon E, Obst J, Gomez-Nicola D. The evolving dialogue of microglia and neurons in Alzheimer\u2019s disease: microglia as necessary transducers of pathology. Neuroscience. 2019;405:24\u201334.","journal-title":"Neuroscience"},{"issue":"2","key":"571_CR249","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","volume":"36","author":"H Lian","year":"2016","unstructured":"Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, Zheng H. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease. J Neurosci. 2016;36(2):577\u201389.","journal-title":"J Neurosci"},{"issue":"1","key":"571_CR250","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","volume":"137","author":"K Saijo","year":"2009","unstructured":"Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, et al. A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell. 2009;137(1):47\u201359.","journal-title":"Cell"},{"issue":"10","key":"571_CR251","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.2174\/138920111798357465","volume":"12","author":"AK Clark","year":"2011","unstructured":"Clark AK, Staniland AA, Malcangio M. Fractalkine\/CX3CR1 signalling in chronic pain and inflammation. Curr Pharm Biotechnol. 2011;12(10):1707\u201314.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"571_CR252","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.expneurol.2008.09.003","volume":"215","author":"DG Walker","year":"2009","unstructured":"Walker DG, Dalsing-Hernandez JE, Campbell NA, Lue LF. Decreased expression of CD200 and CD200 receptor in Alzheimer\u2019s disease: a potential mechanism leading to chronic inflammation. Exp Neurol. 2009;215(1):5\u201319.","journal-title":"Exp Neurol"},{"issue":"2","key":"571_CR253","doi-asserted-by":"publisher","first-page":"254","DOI":"10.14336\/AD.2019.0615","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, Liu Y, Yan S, Du T, Fu X, Gong X, et al. Disease progression-dependent expression of CD200R1 and CX3CR1 in mouse models of Parkinson\u2019s disease. Aging Dis. 2020;11(2):254\u201368.","journal-title":"Aging Dis"},{"key":"571_CR254","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1742-2094-8-154","volume":"8","author":"S Zhang","year":"2011","unstructured":"Zhang S, Wang XJ, Tian LP, Pan J, Lu GQ, Zhang YJ, et al. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson\u2019s disease. J Neuroinflammation. 2011;8:154.","journal-title":"J Neuroinflammation"},{"key":"571_CR255","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1742-2094-9-107","volume":"9","author":"A Lyons","year":"2012","unstructured":"Lyons A, Downer EJ, Costello DA, Murphy N, Lynch MA. Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia. J Neuroinflammation. 2012;9:107.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"571_CR256","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00702-015-1369-5","volume":"122","author":"S Strobel","year":"2015","unstructured":"Strobel S, Grunblatt E, Riederer P, Heinsen H, Arzberger T, Al-Sarraj S, et al. Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer\u2019s disease progression: CX3CL1, TREM2, and PPARgamma. J Neural Transm (Vienna). 2015;122(7):1069\u201376.","journal-title":"J Neural Transm (Vienna)"},{"key":"571_CR257","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1742-2094-7-93","volume":"7","author":"AW Corona","year":"2010","unstructured":"Corona AW, Huang Y, O\u2019Connor JC, Dantzer R, Kelley KW, Popovich PG, et al. Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation. 2010;7:93.","journal-title":"J Neuroinflammation"},{"key":"571_CR258","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbi.2020.07.035","volume":"90","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhu G, Liu D, Zhang X, Liu Y, Yuan T, et al. Subthalamic nucleus deep brain stimulation suppresses neuroinflammation by Fractalkine pathway in Parkinson\u2019s disease rat model. Brain Behav Immun. 2020;90:16\u201325.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"571_CR259","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01155-w","volume":"15","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, Maaser-Hecker A, Tanzi RE. The neuroimmune axis of Alzheimer\u2019s disease. Genome Med. 2023;15(1):6.","journal-title":"Genome Med"},{"issue":"10","key":"571_CR260","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S, et al. The immune system in Parkinson\u2019s disease: what we know so far. Brain. 2024;147(10):3306\u201324.","journal-title":"Brain"},{"key":"571_CR261","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0201-8","volume":"11","author":"H Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez H, Pacheco R. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation. 2014;11:201.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"571_CR262","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1093\/brain\/awaa269","volume":"143","author":"J Galiano-Landeira","year":"2020","unstructured":"Galiano-Landeira J, Torra A, Vila M, Bov\u00e9 J. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson\u2019s disease. Brain. 2020;143(12):3717\u201333.","journal-title":"Brain"},{"issue":"1","key":"571_CR263","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. 2009;119(1):182\u201392.","journal-title":"J Clin Invest"},{"issue":"10","key":"571_CR264","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41590-023-01604-z","volume":"24","author":"W Su","year":"2023","unstructured":"Su W, Saravia J, Risch I, Rankin S, Guy C, Chapman NM, et al. CXCR6 orchestrates brain CD8(+) T cell residency and limits mouse Alzheimer\u2019s disease pathology. Nat Immunol. 2023;24(10):1735\u201347.","journal-title":"Nat Immunol"},{"issue":"1","key":"571_CR265","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.1038\/s41467-025-62405-6","volume":"16","author":"E Terrabuio","year":"2025","unstructured":"Terrabuio E, Pietronigro EC, Bani A, Della Bianca V, Laudanna C, Rossi B, et al. CD103(-)CD8(+) T cells promote neurotoxic inflammation in Alzheimer\u2019s disease via granzyme K-PAR-1 signaling. Nat Commun. 2025;16(1):8372.","journal-title":"Nat Commun"},{"issue":"23","key":"571_CR266","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","volume":"33","author":"AS Harms","year":"2013","unstructured":"Harms AS, Cao S, Rowse AL, Thome AD, Li X, Mangieri LR, et al. MHCII is required for \u03b1-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci. 2013;33(23):9592\u2013600.","journal-title":"J Neurosci"},{"key":"571_CR267","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","volume":"5","author":"C Cebri\u00e1n","year":"2014","unstructured":"Cebri\u00e1n C, Zucca FA, Mauri P, Steinbeck JA, Studer L, Scherzer CR, et al. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun. 2014;5:3633.","journal-title":"Nat Commun"},{"issue":"10","key":"571_CR268","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1007\/s12035-016-0249-9","volume":"54","author":"Z Liu","year":"2017","unstructured":"Liu Z, Huang Y, Cao BB, Qiu YH, Peng YP. Th17 cells induce dopaminergic neuronal death via LFA-1\/ICAM-1 interaction in a mouse model of Parkinson\u2019s disease. Mol Neurobiol. 2017;54(10):7762\u201376.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"571_CR269","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M, et al. Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson\u2019s disease. Cell Stem Cell. 2018;23(1):123-31.e6.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"571_CR270","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41577-023-00960-z","volume":"24","author":"A Liston","year":"2024","unstructured":"Liston A, Pasciuto E, Fitzgerald DC, Yshii L. Brain regulatory T cells. Nat Rev Immunol. 2024;24(5):326\u201337.","journal-title":"Nat Rev Immunol"},{"key":"571_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117721","volume":"181","author":"H Yang","year":"2024","unstructured":"Yang H, Byun MS, Ha NY, Yang J, Park SY, Park JE, et al. A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer\u2019s disease. Biomed Pharmacother. 2024;181:117721.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"571_CR272","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1189\/jlb.0507296","volume":"82","author":"AD Reynolds","year":"2007","unstructured":"Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease. J Leukoc Biol. 2007;82(5):1083\u201394.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"571_CR273","doi-asserted-by":"publisher","first-page":"7998","DOI":"10.1038\/s41467-024-52396-1","volume":"15","author":"X Huang","year":"2024","unstructured":"Huang X, Fowler C, Li Y, Li QX, Sun J, Pan Y, et al. Clearance and transport of amyloid \u03b2 by peripheral monocytes correlate with Alzheimer\u2019s disease progression. Nat Commun. 2024;15(1):7998.","journal-title":"Nat Commun"},{"issue":"3","key":"571_CR274","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.celrep.2013.10.010","volume":"5","author":"JP Michaud","year":"2013","unstructured":"Michaud JP, Bellavance MA, Pr\u00e9fontaine P, Rivest S. Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Rep. 2013;5(3):646\u201353.","journal-title":"Cell Rep"},{"issue":"1","key":"571_CR275","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40478-017-0494-9","volume":"5","author":"AS Harms","year":"2017","unstructured":"Harms AS, Delic V, Thome AD, Bryant N, Liu Z, Chandra S, et al. \u03b1-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Acta Neuropathol Commun. 2017;5(1):85.","journal-title":"Acta Neuropathol Commun"},{"key":"571_CR276","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.expneurol.2017.11.010","volume":"300","author":"AS Harms","year":"2018","unstructured":"Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X, et al. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol. 2018;300:179\u201387.","journal-title":"Exp Neurol"},{"issue":"4","key":"571_CR277","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/mds.28424","volume":"36","author":"SK Nissen","year":"2021","unstructured":"Nissen SK, Ferreira SA, Nielsen MC, Schulte C, Shrivastava K, Hennig D, et al. Soluble CD163 changes indicate monocyte association with cognitive deficits in Parkinson\u2019s disease. Mov Disord. 2021;36(4):963\u201376.","journal-title":"Mov Disord"},{"issue":"16","key":"571_CR278","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1523\/JNEUROSCI.0299-11.2011","volume":"31","author":"G Naert","year":"2011","unstructured":"Naert G, Rivest S. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. J Neurosci. 2011;31(16):6208\u201320.","journal-title":"J Neurosci"},{"issue":"4","key":"571_CR279","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nm1555","volume":"13","author":"J El Khoury","year":"2007","unstructured":"El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med. 2007;13(4):432\u20138.","journal-title":"Nat Med"},{"key":"571_CR280","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1004885","volume":"13","author":"C Qi","year":"2022","unstructured":"Qi C, Liu F, Zhang W, Han Y, Zhang N, Liu Q, et al. Alzheimer\u2019s disease alters the transcriptomic profile of natural killer cells at single-cell resolution. Front Immunol. 2022;13:1004885.","journal-title":"Front Immunol"},{"key":"571_CR281","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.768966","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu Y, Li K, Hu Y, Wang X. Expression of immune related genes and possible regulatory mechanisms in Alzheimer\u2019s disease. Front Immunol. 2021;12:768966.","journal-title":"Front Immunol"},{"key":"571_CR282","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1360687","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Zhang Y, You Y, Huang Z, Wu L, Liang C, et al. Unraveling the mechanisms of NK cell dysfunction in aging and Alzheimer\u2019s disease: insights from GWAS and single-cell transcriptomics. Front Immunol. 2024;15:1360687.","journal-title":"Front Immunol"},{"issue":"9","key":"571_CR283","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s12276-020-00505-7","volume":"52","author":"RH Earls","year":"2020","unstructured":"Earls RH, Lee JK. The role of natural killer cells in Parkinson\u2019s disease. Exp Mol Med. 2020;52(9):1517\u201325.","journal-title":"Exp Mol Med"},{"key":"571_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578154","volume":"382","author":"J Holbrook","year":"2023","unstructured":"Holbrook J, Patel B, Camacho M, Kahanawita L, Greenland J, Williams-Gray CH. Natural killer cells have an activated profile in early Parkinson\u2019s disease. J Neuroimmunol. 2023;382:578154.","journal-title":"J Neuroimmunol"},{"issue":"s1","key":"571_CR285","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.3233\/JPD-223212","volume":"12","author":"KB Menees","year":"2022","unstructured":"Menees KB, Lee JK. New insights and implications of natural killer cells in Parkinson\u2019s disease. J Parkinsons Dis. 2022;12(s1):S83-s92.","journal-title":"J Parkinsons Dis"},{"key":"571_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2025.104928","volume":"409\u2013410","author":"D Daneshjou","year":"2025","unstructured":"Daneshjou D, Nabavi SM, Shams P, Faranoush P, Salari M, Ebrahimi M. The double-edged sword role of natural killer cells in Parkinson\u2019s disease. Cell Immunol. 2025;409\u2013410:104928.","journal-title":"Cell Immunol"},{"issue":"3","key":"571_CR287","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","volume":"22","author":"JC Cruz Hern\u00e1ndez","year":"2019","unstructured":"Cruz Hern\u00e1ndez JC, Bracko O, Kersbergen CJ, Muse V, Haft-Javaherian M, Berg M, et al. Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer\u2019s disease mouse models. Nat Neurosci. 2019;22(3):413\u201320.","journal-title":"Nat Neurosci"},{"issue":"1","key":"571_CR288","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13529","volume":"57","author":"X Xia","year":"2024","unstructured":"Xia X, He X, Zhao T, Yang J, Bi Z, Fu Q, et al. Inhibiting mtDNA-STING-NLRP3\/IL-1\u03b2 axis-mediated neutrophil infiltration protects neurons in Alzheimer\u2019s disease. Cell Prolif. 2024;57(1):e13529.","journal-title":"Cell Prolif"},{"issue":"10","key":"571_CR289","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1038\/s41591-024-03122-3","volume":"30","author":"N Rosenzweig","year":"2024","unstructured":"Rosenzweig N, Kleemann KL, Rust T, Carpenter M, Grucci M, Aronchik M, et al. Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer\u2019s disease. Nat Med. 2024;30(10):2990\u20133003.","journal-title":"Nat Med"},{"issue":"10","key":"571_CR290","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tins.2023.07.005","volume":"46","author":"J Lauritsen","year":"2023","unstructured":"Lauritsen J, Romero-Ramos M. The systemic immune response in Parkinson\u2019s disease: focus on the peripheral immune component. Trends Neurosci. 2023;46(10):863\u201378.","journal-title":"Trends Neurosci"},{"issue":"5","key":"571_CR291","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8(5):349\u201361.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"571_CR292","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000;192(7):1027\u201334.","journal-title":"J Exp Med"},{"issue":"2","key":"571_CR293","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","volume":"11","author":"H Nishimura","year":"1999","unstructured":"Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11(2):141\u201351.","journal-title":"Immunity"},{"issue":"2","key":"571_CR294","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch K, Deczkowska A, Rosenzweig N, Tsitsou-Kampeli A, Sharif AM, Matcovitch-Natan O, et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat Med. 2016;22(2):135\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"571_CR295","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41467-019-08352-5","volume":"10","author":"N Rosenzweig","year":"2019","unstructured":"Rosenzweig N, Dvir-Szternfeld R, Tsitsou-Kampeli A, Keren-Shaul H, Ben-Yehuda H, Weill-Raynal P, et al. PD-1\/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. Nat Commun. 2019;10(1):465.","journal-title":"Nat Commun"},{"issue":"3","key":"571_CR296","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/glia.23260","volume":"66","author":"M Latta-Mahieu","year":"2018","unstructured":"Latta-Mahieu M, Elmer B, Bretteville A, Wang Y, Lopez-Grancha M, Goniot P, et al. Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-\u03b2 burden in several amyloid transgenic mouse models. Glia. 2018;66(3):492\u2013504.","journal-title":"Glia"},{"issue":"24","key":"571_CR297","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108662","volume":"40","author":"MP Kummer","year":"2021","unstructured":"Kummer MP, Ising C, Kummer C, Sarlus H, Griep A, Vieira-Saecker A, et al. Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer\u2019s disease pathology. Embo j. 2021;40(24):e108662.","journal-title":"Embo j"},{"issue":"1","key":"571_CR298","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1038\/s41467-023-43053-0","volume":"14","author":"CM Capelle","year":"2023","unstructured":"Capelle CM, Cir\u00e9 S, Hedin F, Hansen M, Pavelka L, Grzyb K, et al. Early-to-mid stage idiopathic Parkinson\u2019s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. Nat Commun. 2023;14(1):7461.","journal-title":"Nat Commun"},{"issue":"1","key":"571_CR299","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, et al. Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17(1):131\u201343.","journal-title":"Nat Neurosci"},{"issue":"11","key":"571_CR300","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"24","author":"Z Yin","year":"2023","unstructured":"Yin Z, Rosenzweig N, Kleemann KL, Zhang X, Brand\u00e3o W, Margeta MA, et al. APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGF\u03b2-mediated checkpoints. Nat Immunol. 2023;24(11):1839\u201353.","journal-title":"Nat Immunol"},{"key":"571_CR301","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fnmol.2016.00007","volume":"9","author":"SJ Haas","year":"2016","unstructured":"Haas SJ, Zhou X, Machado V, Wree A, Krieglstein K, Spittau B. Expression of Tgf\u03b21 and inflammatory markers in the 6-hydroxydopamine mouse model of Parkinson\u2019s disease. Front Mol Neurosci. 2016;9:7.","journal-title":"Front Mol Neurosci"},{"issue":"7480","key":"571_CR302","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature12776","volume":"504","author":"WS Chung","year":"2013","unstructured":"Chung WS, Clarke LE, Wang GX, Stafford BK, Sher A, Chakraborty C, et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature. 2013;504(7480):394\u2013400.","journal-title":"Nature"},{"issue":"8","key":"571_CR303","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41593-018-0192-3","volume":"21","author":"P Ayata","year":"2018","unstructured":"Ayata P, Badimon A, Strasburger HJ, Duff MK, Montgomery SE, Loh YE, et al. Epigenetic regulation of brain region-specific microglia clearance activity. Nat Neurosci. 2018;21(8):1049\u201360.","journal-title":"Nat Neurosci"},{"issue":"8103","key":"571_CR304","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41586-025-09987-9","volume":"650","author":"IH Guldner","year":"2026","unstructured":"Guldner IH, Wagner VP, Moran-Losada P, Shi SM, Golub SW, Hevler JF, et al. Ageing promotes microglial accumulation of slow-degrading synaptic proteins. Nature. 2026;650(8103):930\u201341.","journal-title":"Nature"},{"issue":"7","key":"571_CR305","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41556-023-01158-0","volume":"25","author":"I Choi","year":"2023","unstructured":"Choi I, Wang M, Yoo S, Xu P, Seegobin SP, Li X, et al. Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence. Nat Cell Biol. 2023;25(7):963\u201374.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"571_CR306","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2023.12.001","volume":"57","author":"A Millet","year":"2024","unstructured":"Millet A, Ledo JH, Tavazoie SF. An exhausted-like microglial population accumulates in aged and APOE4 genotype Alzheimer\u2019s brains. Immunity. 2024;57(1):153-70.e6.","journal-title":"Immunity"},{"key":"571_CR307","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-018-0143-7","volume":"8","author":"SZ Lu","year":"2019","unstructured":"Lu SZ, Guo YS, Liang PZ, Zhang SZ, Yin S, Yin YQ, et al. Suppression of astrocytic autophagy by \u03b1B-crystallin contributes to \u03b1-synuclein inclusion formation. Transl Neurodegener. 2019;8:3.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"571_CR308","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/glia.24626","volume":"73","author":"J Niskanen","year":"2025","unstructured":"Niskanen J, Peltonen S, Ohtonen S, Fazaludeen MF, Luk KC, Giudice L, et al. Uptake of alpha-synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microglia. Glia. 2025;73(1):159\u201374.","journal-title":"Glia"},{"issue":"1","key":"571_CR309","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","volume":"12","author":"S Bido","year":"2021","unstructured":"Bido S, Muggeo S, Massimino L, Marzi MJ, Giannelli SG, Melacini E, et al. Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat Commun. 2021;12(1):6237.","journal-title":"Nat Commun"},{"issue":"2","key":"571_CR310","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10571-022-01216-5","volume":"43","author":"KV Do","year":"2023","unstructured":"Do KV, Hjorth E, Wang Y, Jun B, Kautzmann MI, Ohshima M, et al. Cerebrospinal fluid profile of lipid mediators in Alzheimer\u2019s disease. Cell Mol Neurobiol. 2023;43(2):797\u2013811.","journal-title":"Cell Mol Neurobiol"},{"key":"571_CR311","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.expneurol.2017.11.005","volume":"300","author":"A Kantarci","year":"2018","unstructured":"Kantarci A, Aytan N, Palaska I, Stephens D, Crabtree L, Benincasa C, et al. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer\u2019s disease. Exp Neurol. 2018;300:111\u201320.","journal-title":"Exp Neurol"},{"issue":"1","key":"571_CR312","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s42003-022-03169-3","volume":"5","author":"C Emre","year":"2022","unstructured":"Emre C, Arroyo-Garc\u00eda LE, Do KV, Jun B, Ohshima M, Alcalde SG, et al. Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in App(NL-G-F\/NL-G-F) mice. Commun Biol. 2022;5(1):245.","journal-title":"Commun Biol"},{"issue":"1","key":"571_CR313","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jcmm.16098","volume":"25","author":"Y Wang","year":"2021","unstructured":"Wang Y, Leppert A, Tan S, van der Gaag B, Li N, Schultzberg M, et al. Maresin 1 attenuates pro-inflammatory activation induced by \u03b2-amyloid and stimulates its uptake. J Cell Mol Med. 2021;25(1):434\u201347.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"571_CR314","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","volume":"10","author":"P Krashia","year":"2019","unstructured":"Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, et al. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson\u2019s disease. Nat Commun. 2019;10(1):3945.","journal-title":"Nat Commun"},{"key":"571_CR315","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.12659\/MSM.901995","volume":"23","author":"J Xu","year":"2017","unstructured":"Xu J, Gao X, Yang C, Chen L, Chen Z. Resolvin D1 attenuates Mpp+-induced Parkinson disease via inhibiting inflammation in PC12 cells. Med Sci Monit. 2017;23:2684\u201391.","journal-title":"Med Sci Monit"},{"issue":"1","key":"571_CR316","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-024-04282-x","volume":"50","author":"SA Khodir","year":"2024","unstructured":"Khodir SA, Sweed EM, Faried MA, Abo Elkhair DM, Khalil MM, Afifi KH, et al. Neuroprotective effect of maresin-1 in rotenone-induced Parkinson\u2019s disease in rats: the putative role of the JAK\/STAT pathway. Neurochem Res. 2024;50(1):30.","journal-title":"Neurochem Res"},{"issue":"43","key":"571_CR317","doi-asserted-by":"publisher","first-page":"69347","DOI":"10.18632\/oncotarget.12469","volume":"7","author":"H Baek","year":"2016","unstructured":"Baek H, Ye M, Kang GH, Lee C, Lee G, Choi DB, et al. Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer\u2019s disease model. Oncotarget. 2016;7(43):69347\u201357.","journal-title":"Oncotarget"},{"issue":"Pt 4","key":"571_CR318","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho C, Ait Ahmed D, Aid S, Toly-Ndour C, Chaigneau T, Calle V, et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain. 2016;139(Pt 4):1237\u201351.","journal-title":"Brain"},{"issue":"1","key":"571_CR319","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02685-7","volume":"19","author":"M Badr","year":"2022","unstructured":"Badr M, McFleder RL, Wu J, Knorr S, Koprich JB, H\u00fcnig T, et al. Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-\u03b1-synuclein Parkinson\u2019s disease mice. J Neuroinflammation. 2022;19(1):319.","journal-title":"J Neuroinflammation"},{"key":"571_CR320","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015237","author":"SY Park","year":"2023","unstructured":"Park SY, Yang H, Kim S, Yang J, Go H, Bae H. Alpha-Synuclein-specific regulatory T cells ameliorate Parkinson\u2019s disease progression in mice. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242015237.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"571_CR321","doi-asserted-by":"publisher","first-page":"19471","DOI":"10.1038\/s41598-022-21920-y","volume":"12","author":"AL Thomas","year":"2022","unstructured":"Thomas AL, Lehn MA, Janssen EM, Hildeman DA, Chougnet CA. Naturally-aged microglia exhibit phagocytic dysfunction accompanied by gene expression changes reflective of underlying neurologic disease. Sci Rep. 2022;12(1):19471.","journal-title":"Sci Rep"},{"issue":"7751","key":"571_CR322","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41586-019-1088-4","volume":"568","author":"JV Pluvinage","year":"2019","unstructured":"Pluvinage JV, Haney MS, Smith BAH, Sun J, Iram T, Bonanno L, et al. CD22 blockade restores homeostatic microglial phagocytosis in ageing brains. Nature. 2019;568(7751):187\u201392.","journal-title":"Nature"},{"issue":"1","key":"571_CR323","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-024-00714-y","volume":"19","author":"J Sepulveda","year":"2024","unstructured":"Sepulveda J, Kim JY, Binder J, Vicini S, Rebeck GW. APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward A\u03b2, through P2RY12. Mol Neurodegener. 2024;19(1):24.","journal-title":"Mol Neurodegener"},{"key":"571_CR324","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00228","volume":"9","author":"X Guo","year":"2017","unstructured":"Guo X, Tang P, Chen L, Liu P, Hou C, Zhang X, et al. Amyloid \u03b2-induced redistribution of transcriptional factor EB and lysosomal dysfunction in primary microglial cells. Front Aging Neurosci. 2017;9:228.","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"571_CR325","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13522","volume":"20","author":"HY Tu","year":"2021","unstructured":"Tu HY, Yuan BS, Hou XO, Zhang XJ, Pei CS, Ma YT, et al. \u03b1-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson\u2019s disease. Aging Cell. 2021;20(12):e13522.","journal-title":"Aging Cell"},{"issue":"1","key":"571_CR326","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-024-01816-8","volume":"10","author":"B Hong","year":"2024","unstructured":"Hong B, Ohtake Y, Itokazu T, Yamashita T. Glial senescence enhances \u03b1-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction. Cell Death Discov. 2024;10(1):50.","journal-title":"Cell Death Discov"},{"issue":"7806","key":"571_CR327","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"issue":"1","key":"571_CR328","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41598-020-80889-8","volume":"11","author":"O Elabi","year":"2021","unstructured":"Elabi O, Gaceb A, Carlsson R, Padel T, Soylu-Kucharz R, Cortijo I, et al. Human \u03b1-synuclein overexpression in a mouse model of Parkinson\u2019s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation. Sci Rep. 2021;11(1):1120.","journal-title":"Sci Rep"},{"issue":"7","key":"571_CR329","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s41590-023-01522-0","volume":"24","author":"AS Mendiola","year":"2023","unstructured":"Mendiola AS, Yan Z, Dixit K, Johnson JR, Bouhaddou M, Meyer-Franke A, et al. Defining blood-induced microglia functions in neurodegeneration through multiomic profiling. Nat Immunol. 2023;24(7):1173\u201387.","journal-title":"Nat Immunol"},{"issue":"1","key":"571_CR330","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12974-019-1636-8","volume":"16","author":"RH Earls","year":"2019","unstructured":"Earls RH, Menees KB, Chung J, Barber J, Gutekunst CA, Hazim MG, et al. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice. J Neuroinflammation. 2019;16(1):250.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"571_CR331","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41419-025-07333-5","volume":"16","author":"W Song","year":"2025","unstructured":"Song W, Zhou ZM, Zhang LL, Shu HF, Xia JR, Qin X, et al. Infiltrating peripheral monocyte TREM-1 mediates dopaminergic neuron injury in substantia nigra of Parkinson\u2019s disease model mice. Cell Death Dis. 2025;16(1):18.","journal-title":"Cell Death Dis"},{"issue":"7","key":"571_CR332","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","volume":"20","author":"MS Hipp","year":"2019","unstructured":"Hipp MS, Kasturi P, Hartl FU. The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol. 2019;20(7):421\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"571_CR333","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuron.2024.09.017","volume":"113","author":"LF Jiang-Xie","year":"2025","unstructured":"Jiang-Xie LF, Drieu A, Kipnis J. Waste clearance shapes aging brain health. Neuron. 2025;113(1):71\u201381.","journal-title":"Neuron"},{"key":"571_CR334","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2024.102306","volume":"91","author":"H Huang","year":"2025","unstructured":"Huang H, Ren J, Liu GH. Insights and Interventions in Age-Associated Inflammation. Curr Opin Genet Dev. 2025;91:102306.","journal-title":"Curr Opin Genet Dev"},{"key":"571_CR335","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105028","volume":"144","author":"TI Kam","year":"2020","unstructured":"Kam TI, Hinkle JT, Dawson TM, Dawson VL. Microglia and astrocyte dysfunction in Parkinson\u2019s disease. Neurobiol Dis. 2020;144:105028.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"571_CR336","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/antiox12040918","volume":"12","author":"J Lee","year":"2023","unstructured":"Lee J, Hyun DH. The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases. Antioxidants (Basel). 2023;12(4):918.","journal-title":"Antioxidants (Basel)"},{"key":"571_CR337","doi-asserted-by":"publisher","first-page":"1579511","DOI":"10.3389\/fnins.2025.1579511","volume":"19","author":"J Doroszkiewicz","year":"2025","unstructured":"Doroszkiewicz J, Winkel I, Mroczko B. Comparative analysis of neuroinflammatory pathways in Alzheimer\u2019s disease, Parkinson\u2019s disease, and multiple sclerosis: insights into similarities and distinctions. Front Neurosci. 2025;19:1579511.","journal-title":"Front Neurosci"},{"issue":"1","key":"571_CR338","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-021-02158-3","volume":"18","author":"J Rostami","year":"2021","unstructured":"Rostami J, Mothes T, Kolahdouzan M, Eriksson O, Moslem M, Bergstrom J, et al. Crosstalk between astrocytes and microglia results in increased degradation of alpha-synuclein and amyloid-beta aggregates. J Neuroinflammation. 2021;18(1):124.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"571_CR339","first-page":"23","volume":"26","author":"H Akiyama","year":"2006","unstructured":"Akiyama H. Abeta, tau and alpha-synuclein and glial cells. Nihon Shinkei Seishin Yakurigaku Zasshi. 2006;26(1):23\u201331.","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"issue":"1","key":"571_CR340","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40478-019-0836-x","volume":"7","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Sengupta M, Trojanowski JQ, Lee VMY. Alzheimer\u2019s disease tau is a prominent pathology in LRRK2 Parkinson\u2019s disease. Acta Neuropathol Commun. 2019;7(1):183.","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"571_CR341","doi-asserted-by":"publisher","first-page":"108130","DOI":"10.1016\/j.isci.2023.108130","volume":"26","author":"KJ He","year":"2023","unstructured":"He KJ, Zhang JB, Liu JY, Zhao FL, Yao XY, Tang YT, et al. LRRK2 G2019S promotes astrocytic inflammation induced by oligomeric alpha-synuclein through NF-kappaB pathway. iScience. 2023;26(11):108130.","journal-title":"iScience"},{"issue":"11","key":"571_CR342","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.neurobiolaging.2009.11.019","volume":"32","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Ho P, Yih Y, Chen C, Lee WL, Tan EK. LRRK2 variant associated with Alzheimer\u2019s disease. Neurobiol Aging. 2011;32(11):1990\u20133.","journal-title":"Neurobiol Aging"},{"issue":"13","key":"571_CR343","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3390\/cells12131799","volume":"12","author":"V Mutti","year":"2023","unstructured":"Mutti V, Carini G, Filippini A, Castrezzati S, Giugno L, Gennarelli M, et al. LRRK2 kinase inhibition attenuates neuroinflammation and cytotoxicity in animal models of Alzheimer\u2019s and Parkinson\u2019s disease-related neuroinflammation. Cells. 2023;12(13):1799.","journal-title":"Cells"},{"issue":"1","key":"571_CR344","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/nu13010037","volume":"13","author":"A Megur","year":"2020","unstructured":"Megur A, Baltriukiene D, Bukelskiene V, Burokas A. The microbiota-gut-brain axis and Alzheimer\u2019s disease: Neuroinflammation is to blame? Nutrients. 2020;13(1):37.","journal-title":"Nutrients"},{"key":"571_CR345","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"Sun MF, Shen YQ. Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s disease. Ageing Res Rev. 2018;45:53\u201361.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"571_CR346","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, et al. Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome. 2021;9(1):226.","journal-title":"Microbiome"},{"key":"571_CR347","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109884","volume":"100","author":"H Shen","year":"2020","unstructured":"Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L, et al. New mechanism of neuroinflammation in Alzheimer\u2019s disease: the activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109884.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"571_CR348","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/ijms17020206","volume":"17","author":"I Lopez Gonzalez","year":"2016","unstructured":"Lopez Gonzalez I, Garcia-Esparcia P, Llorens F, Ferrer I. Genetic and transcriptomic profiles of inflammation in neurodegenerative diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies. Int J Mol Sci. 2016;17(2):206.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"571_CR349","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126626","volume":"23","author":"D Pap","year":"2022","unstructured":"Pap D, Veres-Szekely A, Szebeni B, Vannay A. PARK7\/DJ-1 as a therapeutic target in gut-brain axis diseases. Int J Mol Sci. 2022;23(12):6626.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"571_CR350","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","volume":"112","author":"C Lopez-Lee","year":"2024","unstructured":"Lopez-Lee C, Torres ERS, Carling G, Gan L. Mechanisms of sex differences in Alzheimer\u2019s disease. Neuron. 2024;112(8):1208\u201321.","journal-title":"Neuron"},{"issue":"1","key":"571_CR351","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0920-8","volume":"14","author":"CA Mangold","year":"2017","unstructured":"Mangold CA, Wronowski B, Du M, Masser DR, Hadad N, Bixler GV, et al. Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging. J Neuroinflammation. 2017;14(1):141.","journal-title":"J Neuroinflammation"},{"key":"571_CR352","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111821","volume":"212","author":"A Nicoletti","year":"2023","unstructured":"Nicoletti A, Baschi R, Cicero CE, Iacono S, Re VL, Luca A, et al. Sex and gender differences in Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis: a narrative review. Mech Ageing Dev. 2023;212:111821.","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"571_CR353","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ncl.2022.12.001","volume":"41","author":"R Patel","year":"2023","unstructured":"Patel R, Kompoliti K. Sex and gender differences in Parkinson\u2019s disease. Neurol Clin. 2023;41(2):371\u20139.","journal-title":"Neurol Clin"},{"key":"571_CR354","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1388784","volume":"15","author":"BS Alotaibi","year":"2024","unstructured":"Alotaibi BS, Abdel-Rahman Mohamed A, Abd-Elhakim YM, Noreldin AE, Elhamouly M, Khamis T, et al. Exploring the link between pyrethroids exposure and dopaminergic degeneration through morphometric, immunofluorescence, and in-silico approaches: the therapeutic role of chitosan-encapsulated curcumin nanoparticles. Front Pharmacol. 2024;15:1388784.","journal-title":"Front Pharmacol"},{"issue":"1","key":"571_CR355","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03152-1","volume":"21","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Tan X, Tang C. Estrogen-immuno-neuromodulation disorders in menopausal depression. J Neuroinflammation. 2024;21(1):159.","journal-title":"J Neuroinflammation"},{"key":"571_CR356","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.euroneuro.2020.01.015","volume":"33","author":"E Schueller","year":"2020","unstructured":"Schueller E, Paiva I, Blanc F, Wang XL, Cassel JC, Boutillier AL, et al. Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer\u2019s disease patients. Eur Neuropsychopharmacol. 2020;33:101\u201316.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"571_CR357","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","volume":"121","author":"PH Nguyen","year":"2021","unstructured":"Nguyen PH, Ramamoorthy A, Sahoo BR, Zheng J, Faller P, Straub JE, et al. Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, type II diabetes, and amyotrophic lateral sclerosis. Chem Rev. 2021;121(4):2545\u2013647.","journal-title":"Chem Rev"},{"issue":"2","key":"571_CR358","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2271613","volume":"15","author":"T Zhang","year":"2023","unstructured":"Zhang T, Gao G, Kwok LY, Sun Z. Gut microbiome-targeted therapies for Alzheimer\u2019s disease. Gut Microbes. 2023;15(2):2271613.","journal-title":"Gut Microbes"},{"key":"571_CR359","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102637","volume":"104","author":"XP Zhou","year":"2025","unstructured":"Zhou XP, Sun LB, Liu WH, Zhu WM, Li LC, Song XY, et al. The complex relationship between gut microbiota and Alzheimer\u2019s disease: a systematic review. Ageing Res Rev. 2025;104:102637.","journal-title":"Ageing Res Rev"},{"key":"571_CR360","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jare.2022.10.013","volume":"50","author":"S Salim","year":"2023","unstructured":"Salim S, Ahmad F, Banu A, Mohammad F. Gut microbiome and Parkinson\u2019s disease: perspective on pathogenesis and treatment. J Adv Res. 2023;50:83\u2013105.","journal-title":"J Adv Res"},{"key":"571_CR361","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101416","volume":"70","author":"X Dan","year":"2021","unstructured":"Dan X, Wechter N, Gray S, Mohanty JG, Croteau DL, Bohr VA. Olfactory dysfunction in aging and neurodegenerative diseases. Ageing Res Rev. 2021;70:101416.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"571_CR362","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrm2873","volume":"11","author":"P Brundin","year":"2010","unstructured":"Brundin P, Melki R, Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol. 2010;11(4):301\u20137.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"571_CR363","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.869507","volume":"14","author":"B Zong","year":"2022","unstructured":"Zong B, Yu F, Zhang X, Zhao W, Sun P, Li S, et al. Understanding how physical exercise improves Alzheimer\u2019s disease: cholinergic and monoaminergic systems. Front Aging Neurosci. 2022;14:869507.","journal-title":"Front Aging Neurosci"},{"key":"571_CR364","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"issue":"22","key":"571_CR365","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228421","volume":"21","author":"C Marogianni","year":"2020","unstructured":"Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G. Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease. Int J Mol Sci. 2020;21(22):8421.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"571_CR366","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","volume":"29","author":"A Klegeris","year":"2008","unstructured":"Klegeris A, Pelech S, Giasson BI, Maguire J, Zhang H, McGeer EG, et al. Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol Aging. 2008;29(5):739\u201352.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"571_CR367","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0006-8993(00)03082-1","volume":"888","author":"Y Arai","year":"2001","unstructured":"Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y. Alpha-synuclein-positive structures in cases with sporadic Alzheimer\u2019s disease: morphology and its relationship to tau aggregation. Brain Res. 2001;888(2):287\u201396.","journal-title":"Brain Res"},{"key":"571_CR368","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103092","volume":"71","author":"B Kalyanaraman","year":"2024","unstructured":"Kalyanaraman B, Cheng G, Hardy M. Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: relevance to Parkinson\u2019s disease and therapeutic implications. Redox Biol. 2024;71:103092.","journal-title":"Redox Biol"},{"key":"571_CR369","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105721","volume":"169","author":"A Mamais","year":"2022","unstructured":"Mamais A, Kaganovich A, Harvey K. Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson\u2019s disease. Neurobiol Dis. 2022;169:105721.","journal-title":"Neurobiol Dis"},{"issue":"19","key":"571_CR370","doi-asserted-by":"publisher","DOI":"10.3390\/cells12192412","volume":"12","author":"HA Shin","year":"2023","unstructured":"Shin HA, Park M, Lee HJ, Duong VA, Kim HM, Hwang DY, et al. Unveiling neuroprotection and regeneration mechanisms in optic nerve injury: insight from neural progenitor cell therapy with focus on Vps35 and Syntaxin12. Cells. 2023;12(19):2412.","journal-title":"Cells"},{"issue":"3","key":"571_CR371","doi-asserted-by":"publisher","first-page":"682","DOI":"10.4103\/1673-5374.321000","volume":"17","author":"YF Wen","year":"2022","unstructured":"Wen YF, Xiao XW, Zhou L, Jiang YL, Zhu Y, Guo LN, et al. Mutations in GBA, SNCA, and VPS35 are not associated with Alzheimer\u2019s disease in a Chinese population: a case-control study. Neural Regen Res. 2022;17(3):682\u20139.","journal-title":"Neural Regen Res"},{"issue":"667","key":"571_CR372","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn9380","volume":"14","author":"B Zhou","year":"2022","unstructured":"Zhou B, Lu JG, Siddu A, Wernig M, Sudhof TC. Synaptogenic effect of APP-Swedish mutation in familial Alzheimer\u2019s disease. Sci Transl Med. 2022;14(667):eabn9380.","journal-title":"Sci Transl Med"},{"issue":"43","key":"571_CR373","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2509903122","volume":"122","author":"R Zhao","year":"2025","unstructured":"Zhao R, Sophanpanichkul P, Chadarevian JP, Ding Y, Dai H, Nayak M, et al. Amyloid precursor protein and C99 are subunits in human microglial Hv1 channels that enhance current and inflammatory mediator release. Proc Natl Acad Sci USA. 2025;122(43):e2509903122.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"571_CR374","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JAD-2005-7304","volume":"7","author":"M Fiala","year":"2005","unstructured":"Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, et al. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer\u2019s disease patients. J Alzheimers Dis. 2005;7(3):221\u201332 (discussion 55\u201362).","journal-title":"J Alzheimers Dis"},{"key":"571_CR375","doi-asserted-by":"publisher","first-page":"1757306","DOI":"10.3389\/fnagi.2026.1757306","volume":"18","author":"J Jayaprakash","year":"2026","unstructured":"Jayaprakash J, Gizaw ST, Gowda D, Hinou H, Nishimura SI, Hui SP, et al. Brain lipidomics for region-specific biomarker discovery in neurodegenerative diseases. Front Aging Neurosci. 2026;18:1757306.","journal-title":"Front Aging Neurosci"},{"issue":"17","key":"571_CR376","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/1873-3468.14992","volume":"598","author":"M Santos","year":"2024","unstructured":"Santos M, Melo T, Maur\u00edcio T, Ferreira H, Domingues P, Domingues R. The non-enzymatic oxidation of phosphatidylethanolamine and phosphatidylserine and their intriguing roles in inflammation dynamics and diseases. FEBS Lett. 2024;598(17):2174\u201389.","journal-title":"FEBS Lett"},{"issue":"10","key":"571_CR377","doi-asserted-by":"publisher","first-page":"7442","DOI":"10.1111\/ejn.15516","volume":"54","author":"S Singh","year":"2021","unstructured":"Singh S, Kamat SS. The loss of enzymatic activity of the PHARC-associated lipase ABHD12 results in increased phagocytosis that causes neuroinflammation. Eur J Neurosci. 2021;54(10):7442\u201357.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"571_CR378","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1038\/s41598-024-56837-1","volume":"14","author":"T Oka","year":"2024","unstructured":"Oka T, Matsuzawa Y, Tsuneyoshi M, Nakamura Y, Aoshima K, Tsugawa H. Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer\u2019s disease neuroimaging initiative cohort. Sci Rep. 2024;14(1):6797.","journal-title":"Sci Rep"},{"issue":"5","key":"571_CR379","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70003","volume":"24","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chen R, Mu C, Diao J, Guo Y, Yao X, et al. Enhanced microglial engulfment of dopaminergic synapses induces Parkinson\u2019s disease-related executive dysfunction in an acute LPC infusion targeting the mPFC. Aging Cell. 2025;24(5):e70003.","journal-title":"Aging Cell"},{"key":"571_CR380","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.739130","volume":"12","author":"R Zhou","year":"2021","unstructured":"Zhou R, Ji B, Kong Y, Qin L, Ren W, Guan Y, et al. PET Imaging of Neuroinflammation in Alzheimer\u2019s Disease. Front Immunol. 2021;12:739130.","journal-title":"Front Immunol"},{"issue":"3","key":"571_CR381","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-2990.2008.01006.x","volume":"35","author":"M Cosenza-Nashat","year":"2009","unstructured":"Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, et al. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol. 2009;35(3):306\u201328.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"571_CR382","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/brain\/awx120","volume":"140","author":"P Parbo","year":"2017","unstructured":"Parbo P, Ismail R, Hansen KV, Amidi A, Marup FH, Gottrup H, et al. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer\u2019s disease. Brain. 2017;140(7):2002\u201311.","journal-title":"Brain"},{"issue":"5","key":"571_CR383","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/brain\/awaa088","volume":"143","author":"M Malpetti","year":"2020","unstructured":"Malpetti M, Kievit RA, Passamonti L, Jones PS, Tsvetanov KA, Rittman T, et al. Microglial activation and tau burden predict cognitive decline in Alzheimer\u2019s disease. Brain. 2020;143(5):1588\u2013602.","journal-title":"Brain"},{"issue":"4","key":"571_CR384","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/mds.28395","volume":"36","author":"C Palleis","year":"2021","unstructured":"Palleis C, Sauerbeck J, Beyer L, Harris S, Schmitt J, Morenas-Rodriguez E, et al. In vivo assessment of neuroinflammation in 4-repeat tauopathies. Mov Disord. 2021;36(4):883\u201394.","journal-title":"Mov Disord"},{"issue":"16","key":"571_CR385","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.7150\/thno.97149","volume":"14","author":"M Shojaei","year":"2024","unstructured":"Shojaei M, Schaefer R, Schlepckow K, Kunze LH, Struebing FL, Brunner B, et al. PET imaging of microglia in Alzheimer\u2019s disease using copper-64 labeled TREM2 antibodies. Theranostics. 2024;14(16):6319\u201336.","journal-title":"Theranostics"},{"issue":"12","key":"571_CR386","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1007\/s00259-011-1895-9","volume":"38","author":"AF Santillo","year":"2011","unstructured":"Santillo AF, Gambini JP, Lannfelt L, Langstrom B, Ulla-Marja L, Kilander L, et al. In vivo imaging of astrocytosis in Alzheimer\u2019s disease: an (1)(1)C-L-deuteriodeprenyl and PIB PET study. Eur J Nucl Med Mol Imaging. 2011;38(12):2202\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"571_CR387","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2967\/jnumed.115.168732","volume":"57","author":"E Rodriguez-Vieitez","year":"2016","unstructured":"Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Scholl M, et al. Comparison of early-phase 11C-deuterium-l-deprenyl and 11C-pittsburgh compound B PET for assessing brain perfusion in Alzheimer disease. J Nucl Med. 2016;57(7):1071\u20137.","journal-title":"J Nucl Med"},{"issue":"9","key":"571_CR388","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.bbadis.2014.06.020","volume":"1842","author":"KY Shivers","year":"2014","unstructured":"Shivers KY, Nikolopoulou A, Machlovi SI, Vallabhajosula S, Figueiredo-Pereira ME. PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2. Biochim Biophys Acta. 2014;1842(9):1707\u201319.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"571_CR389","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04516-6","volume":"21","author":"LY Fan","year":"2023","unstructured":"Fan LY, Yang J, Liu RY, Kong Y, Guo GY, Xu YM. Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer\u2019s disease, Parkinson\u2019s disease, and multiple sclerosis. J Transl Med. 2023;21(1):649.","journal-title":"J Transl Med"},{"issue":"7","key":"571_CR390","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","volume":"19","author":"R Patani","year":"2023","unstructured":"Patani R, Hardingham GE, Liddelow SA. Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration. Nat Rev Neurol. 2023;19(7):395\u2013409.","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"571_CR391","doi-asserted-by":"publisher","first-page":"8996","DOI":"10.1007\/s12035-024-04124-5","volume":"61","author":"MR Fiorini","year":"2024","unstructured":"Fiorini MR, Dilliott AA, Thomas RA, Farhan SMK. Transcriptomics of human brain tissue in Parkinson\u2019s disease: a comparison of bulk and single-cell RNA sequencing. Mol Neurobiol. 2024;61(11):8996\u20139015.","journal-title":"Mol Neurobiol"},{"key":"571_CR392","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fnins.2019.00235","volume":"13","author":"JP Bennett Jr","year":"2019","unstructured":"Bennett JP Jr, Keeney PM, Brohawn DG. RNA sequencing reveals small and variable contributions of infectious agents to transcriptomes of postmortem nervous tissues from amyotrophic lateral sclerosis, Alzheimer\u2019s disease and Parkinson\u2019s disease subjects, and increased expression of genes from disease-activated microglia. Front Neurosci. 2019;13:235.","journal-title":"Front Neurosci"},{"issue":"9","key":"571_CR393","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.3390\/cells9091966","volume":"9","author":"H Xicoy","year":"2020","unstructured":"Xicoy H, Brouwers JF, Wieringa B, Martens GJM. Explorative combined lipid and transcriptomic profiling of substantia nigra and putamen in Parkinson\u2019s disease. Cells. 2020;9(9):1966.","journal-title":"Cells"},{"issue":"10","key":"571_CR394","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41593-021-00905-6","volume":"24","author":"P Hasel","year":"2021","unstructured":"Hasel P, Rose IVL, Sadick JS, Kim RD, Liddelow SA. Neuroinflammatory astrocyte subtypes in the mouse brain. Nat Neurosci. 2021;24(10):1475\u201387.","journal-title":"Nat Neurosci"},{"issue":"4","key":"571_CR395","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"1","key":"571_CR396","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-023-02919-2","volume":"20","author":"N Stoberl","year":"2023","unstructured":"Stoberl N, Maguire E, Salis E, Shaw B, Hall-Roberts H. Human iPSC-derived glia models for the study of neuroinflammation. J Neuroinflammation. 2023;20(1):231.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"571_CR397","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/glia.24345","volume":"71","author":"LW Jin","year":"2023","unstructured":"Jin LW, di Lucente J, Ruiz Mendiola U, Tang X, Zivkovic AM, Lebrilla CB, et al. The role of FUT8-catalyzed core fucosylation in Alzheimer\u2019s amyloid-beta oligomer-induced activation of human microglia. Glia. 2023;71(5):1346\u201359.","journal-title":"Glia"},{"issue":"10","key":"571_CR398","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.it.2024.08.004","volume":"45","author":"RA Summers","year":"2024","unstructured":"Summers RA, Fagiani F, Rowitch DH, Absinta M, Reich DS. Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine. Trends Immunol. 2024;45(10):799\u2013813.","journal-title":"Trends Immunol"},{"key":"571_CR399","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.740758","volume":"9","author":"K Badanjak","year":"2021","unstructured":"Badanjak K, Mulica P, Smajic S, Delcambre S, Tranchevent LC, Diederich N, et al. iPSC-derived microglia as a model to study inflammation in idiopathic Parkinson\u2019s disease. Front Cell Dev Biol. 2021;9:740758.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"571_CR400","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.tcb.2024.12.001","volume":"35","author":"A Pagliaro","year":"2025","unstructured":"Pagliaro A, Artegiani B, Hendriks D. Emerging approaches to enhance human brain organoid physiology. Trends Cell Biol. 2025;35(6):483\u201399.","journal-title":"Trends Cell Biol"},{"issue":"10","key":"571_CR401","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.cell.2023.04.022","volume":"186","author":"ST Schafer","year":"2023","unstructured":"Schafer ST, Mansour AA, Schlachetzki JCM, Pena M, Ghassemzadeh S, Mitchell L, et al. An in vivo neuroimmune organoid model to study human microglia phenotypes. Cell. 2023;186(10):2111\u201326.","journal-title":"Cell"},{"issue":"1","key":"571_CR402","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, Fu Y, Yamazaki Y, Ren Y, Davis MD, Liu CC, et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun. 2020;11(1):5540.","journal-title":"Nat Commun"},{"issue":"10","key":"571_CR403","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1038\/s41380-025-03041-w","volume":"30","author":"Y Ji","year":"2025","unstructured":"Ji Y, Chen X, Wang Z, Meek CJ, McLean JL, Yang Y, et al. Alzheimer\u2019s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery. Mol Psychiatry. 2025;30(10):4558\u201375.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"571_CR404","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.26166","volume":"90","author":"J Jo","year":"2021","unstructured":"Jo J, Yang L, Tran HD, Yu W, Sun AX, Chang YY, et al. Lewy body-like inclusions in human midbrain organoids carrying glucocerebrosidase and alpha-synuclein mutations. Ann Neurol. 2021;90(3):490\u2013505.","journal-title":"Ann Neurol"},{"issue":"8","key":"571_CR405","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.7150\/thno.80271","volume":"13","author":"X Zheng","year":"2023","unstructured":"Zheng X, Han D, Liu W, Wang X, Pan N, Wang Y, et al. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson\u2019s disease. Theranostics. 2023;13(8):2673\u201392.","journal-title":"Theranostics"},{"issue":"3","key":"571_CR406","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/brain\/awaf326","volume":"149","author":"HD Tran","year":"2026","unstructured":"Tran HD, Shin MK, Yeo XY, Jung S, Junaid M, Lim SB, et al. A human striatal-midbrain assembloid model of alpha-synuclein propagation. Brain. 2026;149(3):867\u201383.","journal-title":"Brain"},{"key":"571_CR407","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09151-3","author":"A Jain","year":"2025","unstructured":"Jain A, Gut G, Sanchis-Calleja F, Tschannen R, He Z, Luginbuhl N, et al. Morphodynamics of human early brain organoid development. Nature. 2025. https:\/\/doi.org\/10.1038\/s41586-025-09151-3.","journal-title":"Nature"},{"issue":"5","key":"571_CR408","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41580-024-00804-1","volume":"26","author":"M Birtele","year":"2025","unstructured":"Birtele M, Lancaster M, Quadrato G. Modelling human brain development and disease with organoids. Nat Rev Mol Cell Biol. 2025;26(5):389\u2013412.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"571_CR409","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12974-023-02747-4","volume":"20","author":"RP Wang","year":"2023","unstructured":"Wang RP, Huang J, Chan KWY, Leung WK, Goto T, Ho YS, et al. IL-1\u03b2 and TNF-\u03b1 play an important role in modulating the risk of periodontitis and Alzheimer\u2019s disease. J Neuroinflammation. 2023;20(1):71.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"571_CR410","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.tins.2008.07.005","volume":"31","author":"W Chadwick","year":"2008","unstructured":"Chadwick W, Magnus T, Martin B, Keselman A, Mattson MP, Maudsley S. Targeting TNF-alpha receptors for neurotherapeutics. Trends Neurosci. 2008;31(10):504\u201311.","journal-title":"Trends Neurosci"},{"key":"571_CR411","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nbd.2017.02.010","volume":"102","author":"KP MacPherson","year":"2017","unstructured":"MacPherson KP, Sompol P, Kannarkat GT, Chang J, Sniffen L, Wildner ME, et al. Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice. Neurobiol Dis. 2017;102:81\u201395.","journal-title":"Neurobiol Dis"},{"key":"571_CR412","doi-asserted-by":"crossref","unstructured":"Jaeger J, Staats KA, Barnum S, Pope P, Kingery L, Buitendyk M, et al. XPro1595, a selective soluble TNF neutralizer, in early Alzheimer\u2019s disease with inflammation (ADi): results from the phase 2 MINDFuL trial. medRxiv. 2025:2025.09.24.25336496.","DOI":"10.1101\/2025.09.24.25336496"},{"issue":"9","key":"571_CR413","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/s41590-025-02230-7","volume":"26","author":"ANR Weber","year":"2025","unstructured":"Weber ANR, McManus RM, Hornung V, Geyer M, Kuemmerle-Deschner JB, Latz E. The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets. Nat Immunol. 2025;26(9):1453\u201366.","journal-title":"Nat Immunol"},{"key":"571_CR414","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109941","volume":"252","author":"RM McManus","year":"2024","unstructured":"McManus RM, Latz E. NLRP3 inflammasome signalling in Alzheimer\u2019s disease. Neuropharmacology. 2024;252:109941.","journal-title":"Neuropharmacology"},{"issue":"9","key":"571_CR415","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.040474","volume":"14","author":"N Chaparro-Cabanillas","year":"2025","unstructured":"Chaparro-Cabanillas N, Aliena-Valero A, Pedragosa J, Pedrosa L, Honores M, Rossinyol-Boladeres M, et al. Protective effects of interleukin-1 inhibition with Anakinra in mouse models of ischemic stroke with and without reperfusion. J Am Heart Assoc. 2025;14(9):e040474.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"571_CR416","first-page":"66","volume":"11","author":"F Fa\u2032ak","year":"2023","unstructured":"Fa\u2032ak F, Buni M, Falohun A, Lu H, Song J, Johnson DH, et al. Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events. J Immunother Cancer. 2023;11(6):66.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"571_CR417","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03277-3","volume":"21","author":"M Liu","year":"2024","unstructured":"Liu M, Pan J, Li X, Zhang X, Tian F, Li M, et al. Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer\u2019s disease mice. J Neuroinflammation. 2024;21(1):282.","journal-title":"J Neuroinflammation"},{"key":"571_CR418","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"571_CR419","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12974-022-02446-6","volume":"19","author":"J Fu","year":"2022","unstructured":"Fu J, Huang Y, Bao T, Liu C, Liu X, Chen X. The role of Th17 cells\/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A. J neuroinflammation. 2022;19(1):98.","journal-title":"J neuroinflammation"},{"issue":"2","key":"571_CR420","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41593-017-0059-z","volume":"21","author":"G Faraco","year":"2018","unstructured":"Faraco G, Brea D, Garcia-Bonilla L, Wang G, Racchumi G, Chang H, et al. Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response. Nat Neurosci. 2018;21(2):240\u20139.","journal-title":"Nat Neurosci"},{"issue":"4","key":"571_CR421","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S2468-1253(22)00427-7","volume":"8","author":"BG Feagan","year":"2023","unstructured":"Feagan BG, Sands BE, Sandborn WJ, Germinaro M, Vetter M, Shao J, et al. Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial. Lancet Gastroenterol Hepatol. 2023;8(4):307\u201320.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"571_CR422","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1158\/1535-7163.MCT-07-2384","volume":"7","author":"BM Tijink","year":"2008","unstructured":"Tijink BM, Laeremans T, Budde M, Stigter-van Walsum M, Dreier T, de Haard HJ, et al. Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology. Mol Cancer Ther. 2008;7(8):2288\u201397.","journal-title":"Mol Cancer Ther"},{"issue":"14","key":"571_CR423","doi-asserted-by":"publisher","first-page":"13121","DOI":"10.1021\/acsnano.2c08275","volume":"17","author":"J Nong","year":"2023","unstructured":"Nong J, Glassman PM, Myerson JW, Zuluaga-Ramirez V, Rodriguez-Garcia A, Mukalel A, et al. Targeted nanocarriers co-opting pulmonary intravascular leukocytes for drug delivery to the injured brain. ACS Nano. 2023;17(14):13121\u201336.","journal-title":"ACS Nano"},{"key":"571_CR424","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"571_CR425","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41590-018-0212-1","volume":"19","author":"WM Song","year":"2018","unstructured":"Song WM, Colonna M. The identity and function of microglia in neurodegeneration. Nat Immunol. 2018;19(10):1048\u201358.","journal-title":"Nat Immunol"},{"issue":"6753","key":"571_CR426","doi-asserted-by":"publisher","DOI":"10.1126\/science.adx0043","volume":"388","author":"FD Shi","year":"2025","unstructured":"Shi FD, Yong VW. Neuroinflammation across neurological diseases. Science. 2025;388(6753):eadx0043.","journal-title":"Science"},{"issue":"22","key":"571_CR427","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, et al. TREM2 drives microglia response to amyloid-beta via SYK-dependent and -independent pathways. Cell. 2022;185(22):4153\u201369.","journal-title":"Cell"},{"issue":"6","key":"571_CR428","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","volume":"23","author":"FL Yeh","year":"2017","unstructured":"Yeh FL, Hansen DV, Sheng M. TREM2, microglia, and neurodegenerative diseases. Trends Mol Med. 2017;23(6):512\u201333.","journal-title":"Trends Mol Med"},{"issue":"622","key":"571_CR429","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe3947","volume":"13","author":"FA Sayed","year":"2021","unstructured":"Sayed FA, Kodama L, Fan L, Carling GK, Udeochu JC, Le D, et al. AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation. Sci Transl Med. 2021;13(622):eabe3947.","journal-title":"Sci Transl Med"},{"issue":"11","key":"571_CR430","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(23)00247-8","volume":"22","author":"K Schlepckow","year":"2023","unstructured":"Schlepckow K, Morenas-Rodr\u00edguez E, Hong S, Haass C. Stimulation of TREM2 with agonistic antibodies-an emerging therapeutic option for Alzheimer\u2019s disease. Lancet Neurol. 2023;22(11):1048\u201360.","journal-title":"Lancet Neurol"},{"issue":"9","key":"571_CR431","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200785","volume":"217","author":"S Wang","year":"2020","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. 2020;217(9):e20200785.","journal-title":"J Exp Med"},{"issue":"661","key":"571_CR432","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang L, Fan X, Li L, Li X, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14(661):eabq0095.","journal-title":"Sci Transl Med"},{"key":"571_CR433","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pneurobio.2017.10.002","volume":"163\u2013164","author":"W Cai","year":"2018","unstructured":"Cai W, Yang T, Liu H, Han L, Zhang K, Hu X, et al. Peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3): a master gatekeeper in CNS injury and repair. Prog Neurobiol. 2018;163\u2013164:27\u201358.","journal-title":"Prog Neurobiol"},{"key":"571_CR434","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fnagi.2019.00178","volume":"11","author":"Q Quan","year":"2019","unstructured":"Quan Q, Qian Y, Li X, Li M. Pioglitazone Reduces \u03b2 Amyloid Levels via Inhibition of PPAR\u03b3 phosphorylation in a neuronal model of Alzheimer\u2019s disease. Front Aging Neurosci. 2019;11:178.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"571_CR435","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","volume":"45","author":"C Titus","year":"2024","unstructured":"Titus C, Hoque MT, Bendayan R. PPAR agonists for the treatment of neuroinflammatory diseases. Trends Pharmacol Sci. 2024;45(1):9\u201323.","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"571_CR436","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s11064-020-02993-5","volume":"45","author":"S Wojtowicz","year":"2020","unstructured":"Wojtowicz S, Strosznajder AK, Jezyna M, Strosznajder JB. The novel role of PPAR alpha in the brain: promising target in therapy of Alzheimer\u2019s disease and other neurodegenerative disorders. Neurochem Res. 2020;45(5):972\u201388.","journal-title":"Neurochem Res"},{"issue":"9","key":"571_CR437","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.it.2020.07.001","volume":"41","author":"KN Green","year":"2020","unstructured":"Green KN, Crapser JD, Hohsfield LA. To kill a microglia: a case for CSF1R inhibitors. Trends Immunol. 2020;41(9):771\u201384.","journal-title":"Trends Immunol"},{"issue":"4","key":"571_CR438","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","volume":"21","author":"Y Huang","year":"2018","unstructured":"Huang Y, Xu Z, Xiong S, Sun F, Qin G, Hu G, et al. Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nat Neurosci. 2018;21(4):530\u201340.","journal-title":"Nat Neurosci"},{"key":"571_CR439","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102919","volume":"58","author":"JD Crapser","year":"2020","unstructured":"Crapser JD, Spangenberg EE, Barahona RA, Arreola MA, Hohsfield LA, Green KN. Microglia facilitate loss of perineuronal nets in the Alzheimer\u2019s disease brain. EBioMedicine. 2020;58:102919.","journal-title":"EBioMedicine"},{"issue":"1","key":"571_CR440","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat Commun. 2019;10(1):3758.","journal-title":"Nat Commun"},{"issue":"2","key":"571_CR441","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14398","volume":"24","author":"M Kodali","year":"2025","unstructured":"Kodali M, Madhu LN, Somayaji Y, Attaluri S, Huard C, Panda PK, et al. Residual microglia following short-term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy. Aging Cell. 2025;24(2):e14398.","journal-title":"Aging Cell"},{"issue":"1","key":"571_CR442","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna J, Philipp S, Albay R 3rd, Reyes-Ruiz JM, Baglietto-Vargas D, LaFerla FM, et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2018;13(1):11.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"571_CR443","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03108-5","volume":"21","author":"AC Stoll","year":"2024","unstructured":"Stoll AC, Kemp CJ, Patterson JR, Kubik M, Kuhn N, Benskey M, et al. Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition. J Neuroinflammation. 2024;21(1):108.","journal-title":"J Neuroinflammation"},{"issue":"6756","key":"571_CR444","doi-asserted-by":"publisher","DOI":"10.1126\/science.adr1015","volume":"389","author":"J Wu","year":"2025","unstructured":"Wu J, Wang Y, Li X, Ouyang P, Cai Y, He Y, et al. Microglia replacement halts the progression of microgliopathy in mice and humans. Science. 2025;389(6756):eadr1015.","journal-title":"Science"},{"issue":"6","key":"571_CR445","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108041","volume":"32","author":"Z Xu","year":"2020","unstructured":"Xu Z, Rao Y, Huang Y, Zhou T, Feng R, Xiong S, et al. Efficient strategies for microglia replacement in the central nervous system. Cell Rep. 2020;32(6):108041.","journal-title":"Cell Rep"},{"issue":"1","key":"571_CR446","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","volume":"2","author":"E Katsyuba","year":"2020","unstructured":"Katsyuba E, Romani M, Hofer D, Auwerx J. NAD(+) homeostasis in health and disease. Nat Metab. 2020;2(1):9\u201331.","journal-title":"Nat Metab"},{"issue":"4","key":"571_CR447","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","volume":"30","author":"S Lautrup","year":"2019","unstructured":"Lautrup S, Sinclair DA, Mattson MP, Fang EF. NAD(+) in brain aging and neurodegenerative disorders. Cell Metab. 2019;30(4):630\u201355.","journal-title":"Cell Metab"},{"key":"571_CR448","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-01959-1","author":"R Thiyagarajan","year":"2025","unstructured":"Thiyagarajan R, Muthaiah R, Sreevelu B, Treanor OP, Redae Y, Berman R, et al. Nicotinamide riboside supplementation restores microglial health and improves cognition in aged male mice. Geroscience. 2025. https:\/\/doi.org\/10.1007\/s11357-025-01959-1.","journal-title":"Geroscience"},{"issue":"1","key":"571_CR449","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12974-021-02250-8","volume":"18","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, et al. NAD(+) improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1\/PGC-1\u03b1 pathway. J Neuroinflammation. 2021;18(1):207.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"571_CR450","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06280-1","volume":"23","author":"J Li","year":"2025","unstructured":"Li J, Cheng XY, Ma RX, Zou B, Zhang Y, Wu MM, et al. Nicotinamide mononucleotide combined with PJ-34 protects microglial cells from lipopolysaccharide-induced mitochondrial impairment through NMNAT3-PARP1 axis. J Transl Med. 2025;23(1):279.","journal-title":"J Transl Med"},{"key":"571_CR451","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2011226118","author":"Y Hou","year":"2021","unstructured":"Hou Y, Wei Y, Lautrup S, Yang B, Wang Y, Cordonnier S, et al. NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer\u2019s disease via cGAS-STING. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2011226118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"571_CR452","doi-asserted-by":"publisher","DOI":"10.3390\/nu15040943","volume":"15","author":"LK Mischley","year":"2023","unstructured":"Mischley LK, Shankland E, Liu SZ, Bhayana S, Fox DJ, Marcinek DJ. ATP and NAD(+) deficiency in Parkinson\u2019s disease. Nutrients. 2023;15(4):943.","journal-title":"Nutrients"},{"issue":"11","key":"571_CR453","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.3390\/biomedicines10112929","volume":"10","author":"IU Rehman","year":"2022","unstructured":"Rehman IU, Khan A, Ahmad R, Choe K, Park HY, Lee HJ, et al. Neuroprotective effects of nicotinamide against MPTP-induced Parkinson\u2019s disease in mice: impact on oxidative stress, neuroinflammation, Nrf2\/HO-1 and TLR4 signaling pathways. Biomedicines. 2022;10(11):2929.","journal-title":"Biomedicines"},{"issue":"1","key":"571_CR454","first-page":"1","volume":"26","author":"JG Birkmayer","year":"1996","unstructured":"Birkmayer JG. Coenzyme nicotinamide adenine dinucleotide: new therapeutic approach for improving dementia of the Alzheimer type. Ann Clin Lab Sci. 1996;26(1):1\u20139.","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"571_CR455","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","volume":"34","author":"B Brakedal","year":"2022","unstructured":"Brakedal B, Dolle C, Riemer F, Ma Y, Nido GS, Skeie GO, et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease. Cell Metab. 2022;34(3):396-407 e6.","journal-title":"Cell Metab"},{"issue":"1","key":"571_CR456","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2374608","volume":"16","author":"S Li","year":"2024","unstructured":"Li S, Cai Y, Guan T, Zhang Y, Huang K, Zhang Z, et al. Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3\/IKK\/NF-\u03baB signaling via gut microbial tryptophan metabolites. Gut Microbes. 2024;16(1):2374608.","journal-title":"Gut Microbes"},{"issue":"1","key":"571_CR457","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40168-023-01471-8","volume":"11","author":"W Pan","year":"2023","unstructured":"Pan W, Zhao J, Wu J, Xu D, Meng X, Jiang P, et al. Dimethyl itaconate ameliorates cognitive impairment induced by a high-fat diet via the gut-brain axis in mice. Microbiome. 2023;11(1):30.","journal-title":"Microbiome"},{"issue":"4","key":"571_CR458","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/nu12041019","volume":"12","author":"F Vinciguerra","year":"2020","unstructured":"Vinciguerra F, Graziano M, Hagn\u00e4s M, Frittitta L, Tumminia A. Influence of the Mediterranean and ketogenic diets on cognitive status and decline: a narrative review. Nutrients. 2020;12(4):1019.","journal-title":"Nutrients"},{"issue":"6","key":"571_CR459","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s12603-022-1807-7","volume":"26","author":"H Hersant","year":"2022","unstructured":"Hersant H, Grossberg G. The ketogenic diet and Alzheimer\u2019s disease. J Nutr Health Aging. 2022;26(6):606\u201314.","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"571_CR460","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/joim.13333","volume":"290","author":"M Guasch-Ferr\u00e9","year":"2021","unstructured":"Guasch-Ferr\u00e9 M, Willett WC. The Mediterranean diet and health: a comprehensive overview. J Intern Med. 2021;290(3):549\u201366.","journal-title":"J Intern Med"},{"key":"571_CR461","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fnut.2016.00022","volume":"3","author":"RJ Hardman","year":"2016","unstructured":"Hardman RJ, Kennedy G, Macpherson H, Scholey AB, Pipingas A. Adherence to a Mediterranean-style diet and effects on cognition in adults: a qualitative evaluation and systematic review of longitudinal and prospective trials. Front Nutr. 2016;3:22.","journal-title":"Front Nutr"},{"key":"571_CR462","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120166","volume":"434","author":"RJ Solch","year":"2022","unstructured":"Solch RJ, Aigbogun JO, Voyiadjis AG, Talkington GM, Darensbourg RM, O\u2019Connell S, et al. Mediterranean diet adherence, gut microbiota, and Alzheimer\u2019s or Parkinson\u2019s disease risk: a systematic review. J Neurol Sci. 2022;434:120166.","journal-title":"J Neurol Sci"},{"issue":"10","key":"571_CR463","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41579-025-01183-w","volume":"23","author":"I Mukhopadhya","year":"2025","unstructured":"Mukhopadhya I, Louis P. Gut microbiota-derived short-chain fatty acids and their role in human health and disease. Nat Rev Microbiol. 2025;23(10):635\u201351.","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"571_CR464","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1210\/clinem\/dgac303","volume":"107","author":"Y Luo","year":"2022","unstructured":"Luo Y, Wang J, Sun L, Gu W, Zong G, Song B, et al. Isocaloric-restricted Mediterranean diet and Chinese diets high or low in plants in adults with prediabetes. J Clin Endocrinol Metab. 2022;107(8):2216\u201327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"571_CR465","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/1753-0407.13015","volume":"12","author":"J Wang","year":"2020","unstructured":"Wang J, Lin X, Bloomgarden ZT, Ning G. The Jiangnan diet, a healthy diet pattern for Chinese. J Diabetes. 2020;12(5):365\u201371.","journal-title":"J Diabetes"},{"issue":"20","key":"571_CR466","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.3390\/nu17203189","volume":"17","author":"M He","year":"2025","unstructured":"He M, Zou Y, Zhang R, Su D, Xu P. Association between the Jiangnan diet and mild cognitive impairment among the elderly. Nutrients. 2025;17(20):3189.","journal-title":"Nutrients"},{"issue":"11","key":"571_CR467","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1002\/alz.13007","volume":"19","author":"AH Dilmore","year":"2023","unstructured":"Dilmore AH, Martino C, Neth BJ, West KA, Zemlin J, Rahman G, et al. Effects of a ketogenic and low-fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(11):4805\u201316.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"571_CR468","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/cns.13779","volume":"28","author":"Y Xu","year":"2022","unstructured":"Xu Y, Jiang C, Wu J, Liu P, Deng X, Zhang Y, et al. Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer\u2019s disease. CNS Neurosci Ther. 2022;28(4):580\u201392.","journal-title":"CNS Neurosci Ther"},{"key":"571_CR469","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","volume":"47","author":"R Nagpal","year":"2019","unstructured":"Nagpal R, Neth BJ, Wang S, Craft S, Yadav H. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019;47:529\u201342.","journal-title":"EBioMedicine"},{"issue":"1","key":"571_CR470","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41531-021-00263-x","volume":"8","author":"C Pellegrini","year":"2022","unstructured":"Pellegrini C, D\u2019Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, et al. Enteric alpha-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson\u2019s disease before brain pathology. NPJ Parkinsons Dis. 2022;8(1):9.","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"571_CR471","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1016\/j.immuni.2023.10.016","volume":"56","author":"HR Peng","year":"2023","unstructured":"Peng HR, Qiu JQ, Zhou QM, Zhang YK, Chen QY, Yin YQ, et al. Intestinal epithelial dopamine receptor signaling drives sex-specific disease exacerbation in a mouse model of multiple sclerosis. Immunity. 2023;56(12):2773-89 e8.","journal-title":"Immunity"},{"key":"571_CR472","doi-asserted-by":"publisher","first-page":"1149618","DOI":"10.3389\/fneur.2023.1149618","volume":"14","author":"R Solanki","year":"2023","unstructured":"Solanki R, Karande A, Ranganathan P. Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration. Front Neurol. 2023;14:1149618.","journal-title":"Front Neurol"},{"issue":"9","key":"571_CR473","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100398","volume":"2","author":"A Ueda","year":"2021","unstructured":"Ueda A, Shinkai S, Shiroma H, Taniguchi Y, Tsuchida S, Kariya T, et al. Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer\u2019s-type dementia. Cell Rep Med. 2021;2(9):100398.","journal-title":"Cell Rep Med"},{"issue":"31","key":"571_CR474","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba0466","volume":"6","author":"C Chen","year":"2020","unstructured":"Chen C, Ahn EH, Kang SS, Liu X, Alam A, Ye K. Gut dysbiosis contributes to amyloid pathology, associated with C\/EBP\u03b2\/AEP signaling activation in Alzheimer\u2019s disease mouse model. Sci Adv. 2020;6(31):eaba0466.","journal-title":"Sci Adv"},{"key":"571_CR475","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1651965","volume":"16","author":"G Kezer","year":"2025","unstructured":"Kezer G, Paramithiotis S, Khwaldia K, Harahap IA, \u010cagalj M, \u0160imat V, et al. A comprehensive overview of the effects of probiotics, prebiotics and synbiotics on the gut-brain axis. Front Microbiol. 2025;16:1651965.","journal-title":"Front Microbiol"},{"issue":"3","key":"571_CR476","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mds.27924","volume":"35","author":"TH Mertsalmi","year":"2019","unstructured":"Mertsalmi TH, Pekkonen E, Scheperjans F. Antibiotic exposure and risk of Parkinson\u2019s disease in Finland: a nationwide case-control study. Mov Disord. 2019;35(3):431\u201342.","journal-title":"Mov Disord"},{"issue":"2","key":"571_CR477","doi-asserted-by":"publisher","first-page":"2284247","DOI":"10.1080\/19490976.2023.2284247","volume":"15","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Tan G, Zhu Q, Wang C, Ruan G, Ying S, et al. Efficacy of fecal microbiota transplantation in patients with Parkinson\u2019s disease: clinical trial results from a randomized, placebo-controlled design. Gut Microbes. 2023;15(2):2284247.","journal-title":"Gut Microbes"},{"issue":"1","key":"571_CR478","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","volume":"10","author":"D Kwon","year":"2024","unstructured":"Kwon D, Zhang K, Paul KC, Folle AD, Del Rosario I, Jacobs JP, et al. Diet and the gut microbiome in patients with Parkinson\u2019s disease. NPJ Parkinsons Dis. 2024;10(1):89.","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"571_CR479","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1038\/s41467-023-38248-4","volume":"14","author":"B Huang","year":"2023","unstructured":"Huang B, Chau SWH, Liu Y, Chan JWY, Wang J, Ma SL, et al. Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives. Nat Commun. 2023;14(1):2501.","journal-title":"Nat Commun"},{"key":"571_CR480","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04318-5","author":"E Menozzi","year":"2026","unstructured":"Menozzi E, Ren Y, Geiger M, Macnaughtan J, Avenali M, Toffoli M, et al. Microbiome signature of Parkinson\u2019s disease in healthy and genetically at-risk individuals. Nat Med.\u00a02026;32(6):2096-2106.","journal-title":"Nat Med"},{"issue":"6","key":"571_CR481","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128(6):805\u201320.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"571_CR482","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103(4):627\u201341.","journal-title":"Neuron"},{"issue":"7618","key":"571_CR483","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"issue":"1","key":"571_CR484","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"571_CR485","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2022;79(1):13\u201321.","journal-title":"JAMA Neurol"},{"issue":"11","key":"571_CR486","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/brain\/awad188","volume":"146","author":"H Hampel","year":"2023","unstructured":"Hampel H, Elhage A, Cho M, Apostolova LG, Nicoll JAR, Atri A. Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics. Brain. 2023;146(11):4414\u201324.","journal-title":"Brain"},{"issue":"4","key":"571_CR487","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370(4):322\u201333.","journal-title":"N Engl J Med"},{"issue":"6760","key":"571_CR488","doi-asserted-by":"publisher","DOI":"10.1126\/science.ads3204","volume":"389","author":"ME Pizzo","year":"2025","unstructured":"Pizzo ME, Plowey ED, Khoury N, Kwan W, Abettan J, DeVos SL, et al. Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA. Science. 2025;389(6760):eads3204.","journal-title":"Science"},{"issue":"545","key":"571_CR489","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1359","volume":"12","author":"MS Kariolis","year":"2020","unstructured":"Kariolis MS, Wells RC, Getz JA, Kwan W, Mahon CS, Tong R, et al. Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys. Sci Transl Med. 2020;12(545):eaay1359.","journal-title":"Sci Transl Med"},{"issue":"4","key":"571_CR490","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med. 2020;12(4):e11227.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"571_CR491","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov. 2022;21(4):306\u201318.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"571_CR492","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40035-025-00490-9","volume":"14","author":"X Zhan","year":"2025","unstructured":"Zhan X, Wen G, Wu X, Li JY. Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials. Transl Neurodegener. 2025;14(1):33.","journal-title":"Transl Neurodegener"},{"issue":"5","key":"571_CR493","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa2202867","volume":"387","author":"G Pagano","year":"2022","unstructured":"Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, et al. Trial of prasinezumab in early-stage Parkinson\u2019s disease. N Engl J Med. 2022;387(5):421\u201332.","journal-title":"N Engl J Med"},{"issue":"4","key":"571_CR494","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","volume":"30","author":"G Pagano","year":"2024","unstructured":"Pagano G, Taylor KI, Anzures Cabrera J, Simuni T, Marek K, Postuma RB, et al. Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease. Nat Med. 2024;30(4):1096\u2013103.","journal-title":"Nat Med"},{"issue":"5","key":"571_CR495","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, et al. Trial of cinpanemab in early Parkinson\u2019s disease. N Engl J Med. 2022;387(5):408\u201320.","journal-title":"N Engl J Med"},{"issue":"8","key":"571_CR496","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/mds.27738","volume":"34","author":"M Brys","year":"2019","unstructured":"Brys M, Fanning L, Hung S, Ellenbogen A, Penner N, Yang M, et al. Randomized phase I clinical trial of anti-\u03b1-synuclein antibody BIIB054. Mov Disord. 2019;34(8):1154\u201363.","journal-title":"Mov Disord"},{"issue":"6","key":"571_CR497","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/mds.29784","volume":"39","author":"L Buur","year":"2024","unstructured":"Buur L, Wiedemann J, Larsen F, Ben Alaya-Fourati F, Kallunki P, Ditlevsen DK, et al. Randomized phase I trial of the \u03b1-Synuclein antibody Lu AF82422. Mov Disord. 2024;39(6):936\u201344.","journal-title":"Mov Disord"},{"issue":"7","key":"571_CR498","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(20)30136-8","volume":"19","author":"D Volc","year":"2020","unstructured":"Volc D, Poewe W, Kutzelnigg A, L\u00fchrs P, Thun-Hohenstein C, Schneeberger A, et al. Safety and immunogenicity of the \u03b1-synuclein active immunotherapeutic PD01A in patients with Parkinson\u2019s disease: a randomised, single-blinded, phase 1 trial. Lancet Neurol. 2020;19(7):591\u2013600.","journal-title":"Lancet Neurol"},{"issue":"7","key":"571_CR499","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/mds.29016","volume":"37","author":"HJ Yu","year":"2022","unstructured":"Yu HJ, Thijssen E, van Brummelen E, van der Plas JL, Radanovic I, Moerland M, et al. A randomized first-in-human study with UB-312, a UBITh\u00ae \u03b1-Synuclein peptide vaccine. Mov Disord. 2022;37(7):1416\u201324.","journal-title":"Mov Disord"},{"issue":"9","key":"571_CR500","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1038\/s41591-024-03101-8","volume":"30","author":"P Eijsvogel","year":"2024","unstructured":"Eijsvogel P, Misra P, Concha-Marambio L, Boyd JD, Ding S, Fedor L, et al. Target engagement and immunogenicity of an active immunotherapeutic targeting pathological \u03b1-synuclein: a phase 1 placebo-controlled trial. Nat Med. 2024;30(9):2631\u201340.","journal-title":"Nat Med"},{"issue":"17","key":"571_CR501","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med. 2009;361(17):1651\u201361.","journal-title":"N Engl J Med"},{"issue":"1","key":"571_CR502","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, et al. Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell. 2011;146(1):37\u201352.","journal-title":"Cell"},{"issue":"4","key":"571_CR503","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","volume":"77","author":"S Mullin","year":"2020","unstructured":"Mullin S, Smith L, Lee K, D\u2019Souza G, Woodgate P, Elflein J, et al. Ambroxol for the treatment of patients with Parkinson Disease with and without glucocerebrosidase gene mutations: A nonrandomized, noncontrolled trial. JAMA Neurol. 2020;77(4):427\u201334.","journal-title":"JAMA Neurol"},{"issue":"9","key":"571_CR504","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1073\/pnas.1220464110","volume":"110","author":"SP Sardi","year":"2013","unstructured":"Sardi SP, Clarke J, Viel C, Chan M, Tamsett TJ, Treleaven CM, et al. Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc Natl Acad Sci USA. 2013;110(9):3537\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"571_CR505","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.nbd.2015.09.009","volume":"82","author":"EM Rocha","year":"2015","unstructured":"Rocha EM, Smith GA, Park E, Cao H, Brown E, Hayes MA, et al. Glucocerebrosidase gene therapy prevents \u03b1-synucleinopathy of midbrain dopamine neurons. Neurobiol Dis. 2015;82:495\u2013503.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"571_CR506","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jalz.2012.11.012","volume":"9","author":"Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial Research Group","year":"2013","unstructured":"Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial Research Group. Results of a follow-up study to the randomized Alzheimer\u2019s disease anti-inflammatory prevention trial (ADAPT). Alzheimers Dement. 2013;9(6):714\u201323.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"571_CR507","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","volume":"7","author":"JC Breitner","year":"2011","unstructured":"Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe HC, et al. Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial. Alzheimers Dement. 2011;7(4):402\u201311.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"571_CR508","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","volume":"30","author":"LJ Thal","year":"2005","unstructured":"Thal LJ, Ferris SH, Kirby L, Block GA, Lines CR, Yuen E, et al. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology. 2005;30(6):1204\u201315.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"571_CR509","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","volume":"11","author":"ADAPT-FS Research Group","year":"2015","unstructured":"ADAPT-FS Research Group. Follow-up evaluation of cognitive function in the randomized Alzheimer\u2019s disease anti-inflammatory prevention trial and its follow-up study. Alzheimers Dement. 2015;11(2):216-25.e1.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"571_CR510","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1212\/WNL.0000000000009277","volume":"95","author":"J Ryan","year":"2020","unstructured":"Ryan J, Storey E, Murray AM, Woods RL, Wolfe R, Reid CM, et al. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. Neurology. 2020;95(3):e320\u201331.","journal-title":"Neurology"},{"key":"571_CR511","doi-asserted-by":"crossref","unstructured":"A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology. 2006;66(5):664\u201371.","DOI":"10.1212\/01.wnl.0000201252.57661.e1"},{"key":"571_CR512","doi-asserted-by":"crossref","unstructured":"A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. Clin Neuropharmacol. 2008;31(3):141\u201350.","DOI":"10.1097\/WNF.0b013e3181342f32"},{"issue":"7","key":"571_CR513","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archneur.2008.65.7.nct70006","volume":"65","author":"BK Martin","year":"2008","unstructured":"Martin BK, Szekely C, Brandt J, Piantadosi S, Breitner JC, Craft S, et al. Cognitive function over time in the Alzheimer\u2019s disease anti-inflammatory prevention trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol. 2008;65(7):896\u2013905.","journal-title":"Arch Neurol"},{"key":"571_CR514","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/B978-0-7020-4086-3.00038-2","volume":"119","author":"E Auriel","year":"2014","unstructured":"Auriel E, Regev K, Korczyn AD. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. Handb Clin Neurol. 2014;119:577\u201384.","journal-title":"Handb Clin Neurol"},{"issue":"8","key":"571_CR515","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"571_CR516","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","volume":"181","author":"A Deczkowska","year":"2020","unstructured":"Deczkowska A, Weiner A, Amit I. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell. 2020;181(6):1207\u201317.","journal-title":"Cell"},{"key":"571_CR517","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00456","volume":"11","author":"H Hampel","year":"2020","unstructured":"Hampel H, Caraci F, Cuello AC, Caruso G, Nistic\u00f2 R, Corbo M, et al. A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer\u2019s disease. Front Immunol. 2020;11:456.","journal-title":"Front Immunol"},{"issue":"1","key":"571_CR518","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12295","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings J, Lee G, Nahed P, Kambar M, Zhong K, Fonseca J, et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement (N Y). 2022;8(1):e12295.","journal-title":"Alzheimers Dement (N Y)"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00571-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:12:55Z","timestamp":1785521575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40035-026-00571-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":518,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1186\/s40035-026-00571-3","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"34"}}